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ABSTRACT
Over one million invasive coronary angiography procedures are performed
annually in patients who experience chest pain or are known to have coronary artery
disease. The procedure is carried out to ascertain the degree of arterial blockage (stenosis)
that hinders blood flow to the heart. A cardiologist performing the procedure determines
the physiological degree of a stenosis by either visual estimation, which is routine
practice, or by invasively measuring fractional flow reserve (𝐹𝐹𝑅), which is the current
gold standard that has been demonstrated to improve patient outcomes and temper the
cost of healthcare. Nevertheless, 𝐹𝐹𝑅 is performed in only 10–20% of patients because it
is invasive, expensive, and requires more radiation exposure.
New computational methods utilizing three-dimensional renderings processed
from coronary angiograms can provide an accurate, highly sensitive, non-invasive
method to assess stenotic significance without using 𝐹𝐹𝑅. While beneficial, this
technique requires intensive computer processing power and calculation runtimes on the
order of several hours. An approach to reduce computational time involves alike
computing of two-dimensional arterial slices cut from the three-dimensional source
renderings.
The main objective was to determine if two-dimensional processing can also
provide an accurate and highly sensitive method to assess stenotic significance at a
fraction of the computational expense. Blood flow was analyzed in five patient cases
below and five patient cases above the commonly accepted 𝐹𝐹𝑅 threshold value for
intervention of 0.80. Following the generation of two orthogonal slices from DICOMderived three-dimensional renderings, pulsing blood flow was simulated with CFD, and
vi

multiphase mean age theory was applied to calculate the mean age of red blood cells as a
diagnostic metric.
Two-dimensional processing typically exhibited a correlation with 𝐹𝐹𝑅 only in
the geometries of vertically-oriented slices. This was ascribed to the possibility of
uncaptured stenotic blood flow characteristics in the limited testing of only two angles of
a full arterial segment. Mean ages for the three-dimensional cases were many orders of
magnitude higher than those of the corresponding two-dimensional cases. This was
attributed to red blood cell collisions and distal recirculatory eddies near a stenosis being
less expressed in the simplicity of the two-dimensional slices when compared to the
complexity of the three-dimensional source renderings.
A mean age threshold for determining stent intervention was estimated for the
two-dimensional cases since limited sample size disallowed rigorous statistical analysis.
The data suggested an arbitrary value equal to ~2.5. Nine out of ten cases correlated with
𝐹𝐹𝑅, with just one false negative diagnosis. In published virtual 𝐹𝐹𝑅 techniques, false
diagnosis typically occurs in 10–13% of the cases.
Computational runtime for two-dimensional cases was less than 2% of the
runtime for corresponding three-dimensional cases. Preliminary results indicate twodimensional processing may efficiently detect and assess stenoses non-invasively,
provided that it holds up to rigorous statistical analysis following testing of at least 80–
100 more cases, plus several additional slice angles.
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I. INTRODUCTION
Cardiovascular diseases are a frequent aggressor of health in today’s society, and
they remain pervasive as a result of easily disregarded risk factors such as poor diet and
sedentary lifestyles. Coronary artery disease (CAD) is the most prominent type of
cardiovascular disease, and it is the leading cause of mortality worldwide. CAD signifies
the existence of inflammatory atherosclerosis affecting the inner wall of coronary arteries
in an occlusive manner. Directly, plaques may accrete in response to fibrosis and
calcification, leading to the thickening of the inner wall of arteries and advancing the
constriction of arterial lumina to cause a stenosis.
The predominance of cardiovascular diseases such as CAD has generated
significant interest in the areas of associated risk factor analysis, prevention, and the
development of uncomplicated diagnosis. Presently, invasive coronary angiography
(ICA) employs catheterization to obtain a moving picture of the coronary system, but a
limitation of this utility arises from its incapacity to enumerate the physiological extent of
stenoses. As a result, the metric of fractional flow reserve (𝐹𝐹𝑅) was developed to assess
the fraction of maximal blood flow that may be achieved in a stenotic artery by
invasively measuring a ratio of pressures distal and proximal to a stenosis. A measured
𝐹𝐹𝑅 value less than 0.80 is the threshold below which a cardiologist intervenes with stent
placement to prevent ischemia. The invasive determination of 𝐹𝐹𝑅 has risen to represent
the current gold standard for decision making on stent placement.
Current research has extended the topic of 𝐹𝐹𝑅 to its use in non-invasive,
computationally-derived techniques such as coronary computed tomography angiography
(coronary CTA). Specifically, fractional flow reserve derived from coronary CTA
1

(𝐹𝐹𝑅𝐶𝑇 ) has emerged to become an innovative and non-invasive technique for evaluation
of stenoses. 𝐹𝐹𝑅𝐶𝑇 is calculated from hyperemic blood flow simulated in arterial
renderings using computational fluid dynamics (CFD) to determine the possibility of
CAD and the extent of stenoses. Its adoption, however, is largely dependent on the
monumentally challenging prospect of the medical industry’s acceptance of coronary
CTA as a successor to ICA.
This thesis investigates a presently competing approach that utilizes CFD and
multiphase mean age theory to unite angiography with a non-invasive stenotic evaluator.
Multiphase mean age theory is a concept founded on principles of residence time
distributions (RTDs) and mean age distributions developed by Danckwerts in the 1950s.
Mean age distributions overcome the limitation of discrete sampling at the system exit
typically associated with RTDs, thereby providing full insight into the spatial distribution
of mixing throughout an entire system volume. Nevertheless, mean age distributions are
largely impractical to develop experimentally due to the contingency of measuring an
applied passive tracer throughout an entire system volume. CFD, however, is an ideal
tool for spatially resolved mixing. Mean age theory and its extension to multiphase
systems, in conjunction with CFD, redefines time as a passive scalar in the transient
advection-diffusion equation, allowing conventionally time-based variables to be
analyzed with a steady-state solution.
The objectives of the work presented in this thesis were to simulate blood flow
through arterial renderings, apply multiphase mean age theory using CFD, and compare a
novel mean age metric determined from two-dimensional arterial slices with those that
are used to detect and assess a stenotic artery determined from corresponding three-

2

dimensional arterial renderings. The most significant outcome if similar results were
obtained between three- and two-dimensional processing would be reduced
computational runtime. A shortcoming of CFD processing of three-dimensional flow
arises from considerably lengthy calculation runtimes. Even with parallel computing on
up to 20 processors, calculations can approach a total duration on the order of several
hours to simulate multiphase flow in a typical three-dimensional segment of an artery.
Simulating flow in a two-dimensional slice of the same segment takes on the order of
about 60 minutes.
With the motivation of the content of this thesis considered, the specific
objectives are:
1) generate two-dimensional arterial slices from three-dimensional source
renderings using computer-aided design software packages;
2) use multiphase mean age theory in conjunction with CFD modeling to simulate
blood flow in five two-dimensional cases above and five two-dimensional
cases below the 0.80 𝐹𝐹𝑅 threshold value; and
3) compare the mean age metric determined from the two-dimensional arterial
slices to those determined from the corresponding three-dimensional source
renderings.

3

II. LITERATURE REVIEW
A. Coronary Artery Disease (CAD)
1. General Information: Pathophysiology and Epidemiology
Coronary artery disease (CAD) is a cardiovascular disease typified by plaque
buildup in the walls of the arteries that supply blood to the heart and other parts of the
body. CAD refers to the process of atherosclerosis pathologically affecting coronary
arteries, and the disease includes a spectrum of consequential diagnoses including angina
pectoris, myocardial infarction, silent myocardial ischemia, and sudden cardiac death
(Hanson et al., 2013). CAD may be more descriptively defined as an inflammatory
disease with lipid and macrophage collection on arterial walls as a result of developing
atherosclerosis (Sun and Xu, 2014).
Atherosclerosis is an inflammatory disease of the inner wall of coronary arteries
that is hastened by the commonly known risk factors of high blood pressure, high
cholesterol, tobacco use, and diabetes. Atherosclerosis is slowly progressive, however,
and it silently develops through fibrosis and calcification (Gerber, 2007). The gradual
accretion of plaques leads to the thickening of the inner wall of arteries, permitting, over
time, the considerable constriction of arterial lumina (Ambrose and Singh, 2015).
Defined as stenosis, the narrowing of arterial passageways is the foundational point of
concern for CAD and its resultant diagnoses. When plaques hinder a coronary lumen and
create a stenosis, blood flow is obstructed, occasionally establishing stable angina
pectoris, a condition characterized by discomfort and pain in the chest. In other cases, the
initiation of platelets and blood coagulation factors may occur if the thinned endothelium
covering non-occlusive, lipid-rich plaques unexpectedly ruptures and exposes thrombotic
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components to blood (Gerber, 2007). As a result, coronary lumen occlusion may occur,
instigating ischemia and imparting the substantially more critical issues of unstable
angina pectoris, myocardial infarction, silent myocardial ischemia, or sudden cardiac
death.
Since CAD develops slowly, strikes unexpectedly, and proliferates through easily
unheeded risk factors (e.g., poor diet and sedentary lifestyles), it is predictably the
leading cause of death worldwide (Finegold et al., 2012), and it is responsible for nearly
7.3 million annual deaths and 58 million disability-adjusted life years lost worldwide
(Sun and Xu, 2014). In the United States, CAD is estimated to affect 16.8 million people
alone (Cassar et al., 2009). With this, an American will have a coronary-related event
approximately every 25 seconds, and someone will die of one every minute (Hanson et
al., 2013). While CAD is the leading cause of morbidity and mortality in advanced
countries, its pervasiveness is amply rising in developing countries as well (Sun and Xu,
2014). This is attributable to the broader issue of cardiovascular disease becoming
widespread as developing countries transition epidemiologically from pestilence and
famine to pandemics and progressive diseases (Cassar et al., 2009). In 2002, out of a
worldwide total of 57 million deaths, around 17 million were due to cardiovascular
disease, and CAD was responsible for nearly half of these cardiovascular deaths (Cassar
et al., 2009). While high income countries have recently seen declines in deaths from
CAD, continued high CAD mortality is persistent elsewhere (Finegold et al., 2012), with
the mortality rate from cardiovascular disease predicted to reach 23.4 million in 2030
(Cassar et al., 2009).
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2. Current State of Diagnosis
The predominance of CAD has sparked widespread interest in risk factor analysis,
prevention, and the development of uncomplicated diagnosis. While risk factors may be
moderated by proper diet and lifestyle, testing, when needed, is sought to become
uncomplicated and non-invasive in pursuance of enabling routine checkup and fulfilling
time-sensitive constraints incumbent upon the disease. The tests currently available for
CAD differ in modality and utility, and they serve to stand in comparison to the gold
standard of invasive coronary angiography. The following list from Hanson et al. (2013)
summarizes the current state of available tests for CAD diagnosis:
a. Electrocardiography (ECG). ECG is the most common test for CAD, and it
serves to map the heart rate rhythm over a duration of time. ECG may show
changes in electrical activity that designate ischemia or indicate previous
complications of mild myocardial infarction. Despite this, ECG is inadequate
for full diagnosis since some patients with CAD may produce ordinary results
if the heart is not under any stress.
b. Stress Test. Stress tests involve heart evaluation during concentrated exercise
usually on a treadmill. Since some signs of CAD may only surface if the heart
is under exertion, ECG and blood pressure monitoring are utilized in parallel
while a patient exercises. A patient may experience angina pectoris, and
possible changes in electrical activity or blood pressure could designate
ischemia. During the test, patients may also face exertional hypotension or
hypertension. Exertional hypotension occurs when the blood pressure decreases
to values lower than the resting systolic pressure, and it regularly signifies
severe heart failure or multivessel CAD. With this, exertional hypertension may
6

also arise, but it is usually not as troublesome as exertional hypotension and is
simply evidence of long-term high blood pressure.
c. Myocardial Perfusion Imaging.

Myocardial perfusion imaging utilizes

radioactive tracers such as thallium and sestamibi to show how well blood
perfuses several areas of the heart. These tests are typically performed with a
stress test. The radioactive substance is injected intravenously, and a special
camera takes images around the heart. Typical myocardium receives more
thallium/sestamibi than myocardium being supplied by an occlusive coronary
artery, so this test can provide partial evidence to the extent of possible CAD.
d. Coronary Artery Calcium Computed Tomography (CT). Coronary artery
calcium CT exploits the presence of calcium-rich components in the plaques
created by atherosclerosis. A cardiac CT scan may be performed and placed in
context of measured levels of calcium deposits. The supposition is that there is
a higher chance of CAD if there is a considerable sum of measured calcium.
The Agatston score quantifies the extent of coronary artery calcification, and it
is ultimately used to strengthen claims of CAD diagnosis.
e. Coronary Computed Tomography Angiography (CTA). Coronary CTA scans
the coronary arteries following the intravenous injection of a radioactive
substance. An X-ray source is used to irradiate the area of pertinence to permit
scans and images of the coronary arteries. Using computer software, algorithms
may construct three-dimensional arterial renderings by linking images together.
As a result, the capacity of coronary occlusion may be seen visually, enabling
informed judgments on CAD diagnosis.
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f. Invasive Coronary Angiography (ICA). Invasive coronary angiography is the
gold standard for CAD diagnosis due to its effectiveness. For this test, a
catheter is threaded to the heart by initial insertion into vessels through the
groin, arm, or neck. The heart receives an injection of a radioactive substance
while angiographs are continually acquired. As a result, a moving picture of the
coronary system is obtained, providing specific information about the valves
and arterial function. Important details such as wall motion abnormalities and
left ventricle ejection fraction may be easily evaluated from the angiograms to
provide supportive consensus of CAD diagnosis.
The current state of available tests for CAD diagnosis may be tabulated with additional
metrics. Hanson et al. (2013) provide the comparison of test sensitivity, specificity,
advantages, and disadvantages shown in TABLE 2.1:
TABLE 2.1
A COMPARISON OF TESTS USED FOR CAD DIAGNOSIS
Test
ECG

Sensitivity [%]
68

Specificity [%]
97

Advantages
Inexpensive
Well validated,
inexpensive,
readily available

Disadvantages
–
Less useful for
those with atypical
CAD presentation

Stress Test

Females: 31–33
Males: 68

Females: 52–76
Males: 77

Myocardial
Perfusion Imaging

90

70

High sensitivity

Expensive
Low specificity

Coronary Artery
Calcium CT

91

46

Adds prognostic
value to
intermediate risk
group

Coronary CTA

94

82

Non-invasive

ICA

–

–

Gold standard

New modality,
expensive,
radiation exposure
Invasive,
expensive,
radiation exposure

Test sensitivity and specificity refer, respectively, to the ability of a test to correctly
identify those with the disease and the ability of the test to correctly identify those
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without the disease. Using these metrics, the two angiographic techniques shown in
TABLE 2.1 represent the best methods of examination yet simply differ in procedural
ideation and execution.
B. Fractional Flow Reserve (𝐹𝐹𝑅) in Angiography
1. Definition
While coronary angiographic techniques represent the preferred forms of
diagnostics, a shortcoming of their value stems from their inability to characterize the
physiological magnitude of stenoses. For hearts with normal myocardium and arteries,
blood flow may increase three to five times in response to hyperemia induced by
temporary occlusion (Lederman et al., 1997). For hearts with normal myocardium and a
stenosis, the hyperemic myocardial flow gradually dampens with increasing percentages
of stenosis, beginning at about 50% (Lederman et al., 1997). At that percentage, a
stenosis is considered to impede full flow capability, thereby substantiating physiological
impact. Importantly, angiographic techniques are unreliable in predicting functional flow
consequences of a stenosis, meaning other approaches must be applied to further develop
the physiological merit of angiographic diagnoses of CAD.
Various methods have been used in an attempt to physiologically assess coronary
stenoses, but the concept of fractional flow reserve (𝐹𝐹𝑅) has gained the most attention
for clinical utility due to its emergence as a quick and accurate physiological appraisal
technique (Lederman et al., 1997). 𝐹𝐹𝑅 is defined as the ratio of flow across a stenosis to
putative flow in the absence of stenosis (Nørgaard et al., 2015). As a result, 𝐹𝐹𝑅
enumerates the fraction of maximal blood flow that may be achieved in a stenotic artery.
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Pijls et al. (1996) utilized the research on coronary flow reserve (𝐶𝐹𝑅) from
Gould et al. (1974) to develop a model using translational pressure gradients to
mathematically describe 𝐹𝐹𝑅. While 𝐶𝐹𝑅 is similar in its definition to 𝐹𝐹𝑅, its gauging
relies on direct flow measurement. Pijls et al. (1996) overcame direct flow measurement
reliance by modifying Poiseuille’s law, permitting the establishment of the concept of
𝐹𝐹𝑅. Under Poiseuille’s law, the volumetric flow rate of a fluid is proportional to the
pressure drop across the associated zone of interest and inversely proportional to flow
resistance in that same zone. As such, the pressure drop across the resistance governs the
volumetric flow rate through a resistant artery (Lederman et al., 1997). Supposing the
myocardium is supplied by an artery with a stenosis, the pressure drop is obtained by
subtracting the venous pressure from the pressure distal to the stenosis (i.e., 𝑝𝑑 − 𝑝𝑣 )
(Lederman et al., 1997). With this, supposing the same artery were not stenotic, the
pressure drop calculation shifts to a difference in arterial and venous pressures (i.e., 𝑝𝑎 −
𝑝𝑣 ) (Lederman et al., 1997). Volumetric flow rates are obtained by dividing each pressure
drop by resistance 𝑅, and a ratio of these volumetric flow rates gives:
(𝑝 −𝑝 )/𝑅

𝑝 −𝑝

𝐹𝐹𝑅 = (𝑝𝑑−𝑝𝑣)/𝑅 = 𝑝𝑑−𝑝𝑣
𝑎

𝑣

𝑎

𝑣

(2.1)

If, as in many circumstances, venous pressure is not elevated, Lederman et al. (1997)
suggest 𝑝𝑣 may be excluded to give a simpler ratio:
𝑝

𝐹𝐹𝑅 = 𝑝𝑑
𝑎

(2.2)

For normal arteries, 𝐹𝐹𝑅 is unity since 𝑝𝑑 equals 𝑝𝑎 . For stenotic arteries, however, the
pressure drop increases as occlusion increases, meaning 𝑝𝑑 and 𝐹𝐹𝑅 decrease.
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2. Use in ICA and the Extension to Coronary CTA
The use of 𝐹𝐹𝑅 in ICA procedures represents the current gold standard for
determining whether an arterial stenosis causes ischemia (Min et al., 2015). 𝐹𝐹𝑅
calculation begins with the induction of hyperemia with intravenous adenosine to collect
physiological data on the flow resistance a stenosis is causing (Lederman et al., 1997).
Using a catheter, a sensor collects the required pressures at the necessary locations across
the suspected stenosis, calculating a value of 𝐹𝐹𝑅. An 𝐹𝐹𝑅 less than or equal to 0.80 is
usually recognized as the limit below which a stenosis is considered to cause ischemia
(Min et al., 2015). Knowing this threshold value, clinical strategies regarding subsequent
procedural actions may be targeted appropriately. Specifically, coronary intervention may
be safely deferred for vessels with an 𝐹𝐹𝑅 greater than 0.80, while coronary
revascularization is recommended for vessels with a measured 𝐹𝐹𝑅 less than or equal to
0.80 (Min et al., 2015). In establishing a decisive threshold value of 𝐹𝐹𝑅, improved
clinical outcomes and reduced costs have been seen when compared to an ICA only, non𝐹𝐹𝑅 examination (Min et al., 2015). Ultimately, the addition of the physiological
component of 𝐹𝐹𝑅 to ICA’s anatomically-based evaluations of stenosis severity facilitate
proper coronary actions that are enduring and cost-effective (Min et al., 2012). As of yet,
however, this methodology unifying physiological and anatomical components has not
been available through non-invasive techniques.
In an attempt to establish a non-invasive test that quantifies both coronary stenosis
severity and the associated ischemia, research has increased in the topic of 𝐹𝐹𝑅 to extend
its use in non-invasive coronary CTA. As a result, fractional flow reserve derived from
coronary CTA (𝐹𝐹𝑅𝐶𝑇 ) has emerged to become an innovative and non-invasive method
11

for precise analysis of coronary ischemia caused by a stenosis. 𝐹𝐹𝑅𝐶𝑇 utilizes
computational fluid dynamics (CFD) to assess the physiological extent of CAD.
Importantly, CFD may be used to calculate a value of 𝐹𝐹𝑅𝐶𝑇 from previously acquired
coronary CTA images without the need for further tomographic steps (Min et al., 2015).
Computing 𝐹𝐹𝑅𝐶𝑇 from coronary CTA images necessitates the generation of a
physiological model of coronary blood flow, and Nørgaard et al. (2015) describe the
principles on which the model is established. Specifically, the first principle maintains
that the sum of resting coronary blood flow may be computed relative to the mass of
myocardium assessed by CT. The second principle asserts that the resting vascular
resistance is inversely proportional to the size of the coronary arteries supplying the
myocardium. Finally, the third principle states that the vasodilatory response to adenosine
introduction is predictable, allowing computational modeling of hyperemia. With these
principles established, Min et al. (2015) outline the five required steps for 𝐹𝐹𝑅𝐶𝑇
calculation:
1) create patient-specific anatomical models from coronary CTA;
2) quantify the coronary artery flow in the hypothetical case in which the
supplying vessels are normal;
3) determine the baseline resistance for the arteries supplying the myocardium;
4) quantify the changes in coronary resistance as a result of hyperemia; and
5) apply CFD methods for calculation of coronary flow, pressure, and velocity at
hyperemia.
The grouping of the principles into three-dimensional computational models and the
execution of the five steps permit the calculation of metrics at every point in the coronary
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system under normal and hyperemic conditions. In doing so, 𝐹𝐹𝑅𝐶𝑇 is thusly determined
in an analogous manner to its invasive form in ICA.
The utilization of CFD to evaluate coronary CTA images enables the computation
of arterial blood flow and the calculation of stenosis-specific 𝐹𝐹𝑅𝐶𝑇 without the need for
an invasive procedure. This is to say the computation of 𝐹𝐹𝑅𝐶𝑇 enables the identification
of patients with physiologically significant stenoses prior to invasive cardiac
catheterization. Moreover, the utility of 𝐹𝐹𝑅𝐶𝑇 is underscored by its investigative
potential in modeling innocuous revascularization procedures. Kim et al. (2014) show
that the same CFD technology could be used to modify stenoses of existing flow models
to visualize virtual stenting of a pertinent coronary area. In doing so, coronary blood flow
and 𝐹𝐹𝑅𝐶𝑇 could be recalculated from the new model and be used to validate the
circulatory effect of the stent on a stenosis-specific basis. Ultimately, the prediction of
revascularization benefit via virtual approaches extends the continual non-invasive value
of coronary CTA and its associated 𝐹𝐹𝑅𝐶𝑇 .
3. Clinical Comparison of 𝐹𝐹𝑅 and 𝐹𝐹𝑅𝐶𝑇
While 𝐹𝐹𝑅𝐶𝑇 calculation is proven beneficial with regards to characterizing
arterial blood flow and identifying physiologically significant coronary stenoses, its
comparison to 𝐹𝐹𝑅 from a clinical perspective is principal in efficacy and applicability
determination. Since its incipience of viability within the past decade, 𝐹𝐹𝑅𝐶𝑇 has gained
clinical evidence that may be compared to the diagnostic performance of an invasive
𝐹𝐹𝑅 reference standard (Min et al., 2015). Using a blinded comparison of 𝐹𝐹𝑅𝐶𝑇 to
𝐹𝐹𝑅, trials involving over 600 patients and 1000 vessels assessing the diagnostic
functionality of 𝐹𝐹𝑅𝐶𝑇 in recognizing ischemia caused by stenosis in CAD-related
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instances have been executed (Nørgaard et al., 2015). Using prospective designs with
demarcations of obstructive CAD at stenoses greater than 50% and ischemia at 𝐹𝐹𝑅 or
𝐹𝐹𝑅𝐶𝑇 values less than or equal to 0.80, Nørgaard et al. (2015) provide the comparison of
design, population, test accuracy, sensitivity, and specificity of the studies shown in
TABLE 2.2:
TABLE 2.2
STUDIES COMPARING 𝐹𝐹𝑅𝐶𝑇 DIAGNOSTIC PERFORMANCE USING 𝐹𝐹𝑅 AS
THE REFERENCE STANDARD
Study

Design

DISCOVERFLOW

Statistically
powered on a
per-vessel
basis,
4 centers

De-FACTO

Statistically
powered on a
per-patient
basis,
17 centers

NXT

Statistically
powered on a
per-patient
basis,
10 centers

Population
Patients with suspected or
known CAD who underwent
coronary CTA, ICA, and
𝐹𝐹𝑅. All patients had at least
one stenosis ≥ 50% in a
major vessel at coronary
CTA.
103 patients (159 vessels)
Mean age: 63 years
26% female, 74% male
Proportion of vessels with
𝐹𝐹𝑅 ≤ 0.80: 56%
Patients with suspected or
known CAD who underwent
clinically indicated nonemergent ICA after coronary
CTA (< 60 days), and with at
least one ICA stenosis 30–
90%
252 patients (408 vessels)
Mean age: 63 years
29% female, 71% male
Proportion of patients with
𝐹𝐹𝑅 ≤ 0.80: 53 %
Patients suspected of CAD
who underwent coronary
CTA and ICA within < 60
days
254 patients (484 vessels)
Mean age: 64 years
36% female, 64% male
Proportion of patients with
𝐹𝐹𝑅 ≤ 0.80: 32 %
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Accuracy
[%]

Sensitivity
[%]

Specificity
[%]

84

88

82

73

90

54

81

86

79

The values listed in TABLE 2.2 represent per-vessel and per-patient diagnostic metrics
for 𝐹𝐹𝑅𝐶𝑇 all greater than or equal to respective percentages for coronary CTA alone.
For example, Nørgaard et al. (2015) report that the DISCOVER-FLOW study was
concluded by obtaining per-vessel diagnostic accuracy of 84% for 𝐹𝐹𝑅𝐶𝑇 compared to
59% for coronary CTA alone, and this arose by specificity increasing from 40% for
coronary CTA alone to 82% for 𝐹𝐹𝑅𝐶𝑇 . This shows the aptitude of 𝐹𝐹𝑅𝐶𝑇 in diagnosing
CAD when compared to using coronary CTA on its own. With this, Nørgaard et al.
(2015) also report an increased capacity to discern ischemia on a per-vessel and perpatient basis. This is due to consistent increases in respective area under receiver
operating characteristics curves—a measure of how well a parameter can distinguish
between two diagnostic groups (i.e., having and not having ischemia)—for each
percentage entry in TABLE 2.2. As a result, 𝐹𝐹𝑅𝐶𝑇 derived from coronary CTA images
using 𝐹𝐹𝑅 as the reference standard provides high diagnostic performance in patients
with supposed CAD, thereby encouraging its use as an efficacious tool capable of
delivering increased analytical sensitivity for anatomical evaluation of the disease and
high specificity for physiological detection of accompanying ischemia. Ultimately,
however, the widespread adoption of 𝐹𝐹𝑅𝐶𝑇 is dependent on the exigent prospect of the
medical industry accepting coronary CTA as a successor to ICA.
C. Computational Fluid Dynamics (CFD)
1. General Information: Conservation and Discretization
Computational fluid dynamics (CFD) is a segment of fluid mechanics that solves
fluid flow problems by employing numerical methods and data processing techniques.
CFD is based on transport phenomena, where the conservations of mass, momentum, and
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energy are of distinct importance. CFD programs offer the ability to solve these otherwise
impractical conservation equations effectively and simultaneously. By solving the
conservation equations using a discretized version of a geometric domain, ANSYS
programs such as Fluent and CFX can simulate fluid flow and calculate relevant fluid
metrics of user-based preference. In general, these programs have become ubiquitous in
modeling, permitting the simulation of flow, heat transfer, and reactions for industrial
applications—ranging from air flow over an aircraft wing to combustion in a furnace,
from bubble columns to oil platforms, and from blood flow to wastewater treatment
plants (Software: CFD Simulation, 2017).
The combination of governing conservation equations used to solve CFD cases
depend on the individual system to be modeled. While the equation for energy
conservation is only necessary for problems involving energy transfer, all systems must
solve the conservation equations of mass and momentum. For the conservation equation
of mass, continuity is described by:
𝜕𝜌
𝜕𝑡

+ (∇ ⋅ 𝜌𝑣⃗) = 𝑆𝑚

(2.3)

The conservation equation of momentum is:
𝜕
𝜕𝑡

(𝜌𝑣⃗) + ∇ ⋅ 𝜌𝑣⃗𝑣⃗ = −∇𝑝 − [∇ ⋅ 𝝉] + 𝜌𝑔⃗

(2.4)

The viscous momentum flux tensor 𝝉 represents shear stress and is given by:
2

𝝉 = −𝜇[∇𝑣⃗ + (∇𝑣⃗)𝑇 ] + 3 𝜇(∇ ⋅ 𝑣⃗)𝜹

(2.5)

Assuming constant fluid density and viscosity, substitution of 𝝉 in the conservation
equation of momentum and rearrangement gives the Navier-Stokes equation:
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⃗⃗
𝜕𝑣

𝜌 ( 𝜕𝑡 + 𝑣⃗ ⋅ ∇𝑣⃗) = −∇𝑝 + 𝜇∇2 𝑣⃗ + 𝜌𝑔⃗

(2.6)

The conservation of mass and Navier-Stokes equations are solved in CFD
software by approximating the continuous variables in the partial differentials by discrete
analogs and utilizing a discretized domain of a geometric mesh or grid. While continuous
domains have flow variables defined at every point on the domain, discrete ones have
flow variables defined only at the grid nodes. If each node interacts with adjacent nodes
predictably, an accurate solution may be obtained. If the grid resolution (i.e., mesh count)
is sufficient, discretized results approach analytical ones.
The simplest technique of discretization comes from the finite-difference method.
For illustration of this method, Bhaskaran and Collins (2002) utilize a linear onedimensional differential equation:
𝑑𝑢
𝑑𝑥

+ 𝑢 = 0; 0 ≤ 𝑥 ≤ 1; 𝑢(0) = 1

(2.7)

The domain may be discretized into equally-spaced points on a grid, with general grid
points labeled 𝑥𝑖 . Since the governing equation is valid for all 𝑥𝑖 , the discretized form of
Equation (2.7) is:
𝑑𝑢

(𝑑𝑥 ) + 𝑢𝑖 = 0
𝑖

(2.8)

To get an equation for the differential term in terms of 𝑢 at the grid points, a Taylor series
expansion may be used to give:
𝑑𝑢

(𝑑𝑥 ) =
𝑖

𝑢𝑖 −𝑢𝑖−1
∆𝑥

+ 𝑂(∆𝑥)

Excluding higher-order terms in the Taylor series, an algebraic equation is produced:
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(2.9)

𝑢𝑖 −𝑢𝑖−1
∆𝑥

+ 𝑢𝑖 = 0

(2.10)

While the finite-difference method is simple, it illustrates the foundational discretization
process. An extension to this technique that Fluent coding uses is the finite-volume
method. In this method, integral forms of the conservation equations are applied to a cell
of control volume to obtain discrete equations for each cell. The adjacency of control
volumes creates a network of cells (i.e., a mesh), and the cells may be represented by a
wide range of geometries, including those of quadrilaterals, triangles, hexahedra,
tetrahedra, or prisms. An example of this method is illustrated by the integral form of the
conservation equation of mass:
∫𝑆 (𝑣⃗ ⋅ 𝑛̂)𝑑𝑆 = 0

(2.11)

Using an example square cell of length ∆𝑥, height ∆𝑦, and an imparting velocity vector
of 𝑎𝑖 𝑖̂ + 𝑏𝑖 𝑗̂, the discretized form of the integral equation is:
−𝑎1 ∆𝑦 − 𝑏2 ∆𝑥 + 𝑎3 ∆𝑦 + 𝑏4 ∆𝑥 = 0

(2.12)

Markedly, this equation sums the net mass flow into the control volume of the example
square cell and sets it equal to zero. By similar treatment, discrete equations for
remaining conservation equations for the cell may be achieved. Moreover, the finitevolume method is readily extendable to any other general cell shapes in two or three
dimensions.
After discretization, equations are solved simultaneously and iteratively. Fluent
permits choices between pressure-based and density-based solvers for iteration.
Historically speaking, the pressure-based approach was developed for low-speed
incompressible flows, while the density-based approach was mainly used for high-speed
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compressible flows (Overview of Flow Solvers, 2009). Recently, however, both methods
have been extended to solve and operate for a wide range of flow conditions beyond their
traditional intent. In both methods, the velocity field is obtained from the conservation of
momentum equation. For the pressure-based solver, the pressure field is extracted by
solving a pressure equation obtained by manipulating conservation of mass and
momentum equations. In the density-based approach, the conservation of mass equation
is used to obtain the density field while the pressure field is determined from the equation
of state. Several steps in the chosen iteration scheme must occur to advance the system to
solution convergence. The two approaches of iteration schemes and the steps used to
solve fluid flow problems are shown in FIGURE 2.1:

(b)

(a)

FIGURE 2.1 - Iteration Schemes for the (a) Pressure-based and (b) Density-based Solvers
(Overview of Flow Solvers, 2009)
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Importantly, regardless of the solver used, convergence is checked by evaluating how
much fluid properties have changed from the previous iteration to the current one. If the
change (i.e., residual) is sufficiently small, the solution is converged. If not, the fluid
properties are used as initial values for the next iteration, and the scheme repeats.
2. Utilization in Multiphase Systems
Recent advances in CFD have provided the basis for mathematically modeling the
dynamics of multiphase systems. These systems are characterized by coexisting flow of
materials with different phases (e.g., a liquid-gas system) or materials with differing
chemical properties in the same phase (e.g., a water-oil system). The Euler-Lagrange and
Euler-Euler methods are the two current approaches used for modeling these multiphase
systems. The Euler-Lagrange approach treats the fluid phase as a continuum by solving
the time-averaged Navier-Stokes equations and solves the dispersed phase by tracking
many particles, bubbles, or droplets through the calculated flow field (Overview, 2006).
While the dispersed phase can exchange momentum, mass, and energy with the fluid
phase, the Euler-Lagrange approach relies on the fundamental assumption that the
dispersed phase occupies a low volume fraction. The particle, bubble, or droplet
trajectories are computed individually at specified intervals during the fluid phase
calculation, meaning intensive computational processing requirements are needed.
The Euler-Euler approach is dissimilar by its treatment of both phases as
interpenetrating continua (Approaches to Multiphase Modeling, 2006). Since both phases
are considered continuous, the concept of phasic volume fraction is used. These volume
fractions are assumed to be continuous functions of space and time and their sum equal to
one. Conservation equations for each phase are implemented to obtain a set of similarly
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structured equations for all phases. In Fluent, three different Euler-Euler multiphase
models are available: volume of fluid, mixture, and Eulerian.
The volume of fluid method is a surface-tracking technique applied to a fixed
Eulerian mesh (Approaches to Multiphase Modeling, 2006). It is used for two or more
immiscible fluids, with the interface between the fluids being of most interest. In this
model, the fluids share a single set of momentum equations, and the volume fraction of
each of the fluids in each discretized cell is tracked across the domain. Applications of
the volume of fluid method include the modeling of spray dryers and coal and liquid fuel
combustion. Alternatively, the mixture model solves for the mixture momentum equation
and assigns relative velocities to describe the dispersed phases, making it appropriate for
modeling systems of sedimentation or cyclone operators that are rich with particles.
Finally, the Eulerian model is the most complex of the multiphase models in Fluent, and
it solves a large set of continuity and momentum equations for each phase and couples
the pressure and interphase exchange coefficients as a way to link solutions for each
phase (Approaches to Multiphase Modeling, 2006). Momentum exchange between the
phases is dependent upon the type of mixture being modeled (e.g., granular or nongranular). Fluent's user-defined functions permit customization of the calculation of
momentum exchange. Applications of the Eulerian method include bubble columns and
arterial blood flow.
D. Age Topics
1. Residence Time Distributions (RTDs) and Mean Age Theory
Extensive analysis of residence time distribution (RTD) and age concepts began
in the 1950s with Danckwerts. Before his research, the ideal mixing absolutes of none
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(i.e., plug flow) or perfect (i.e., CSTR) were only considered and characterized, leaving a
void in portraying real processes between these extrema. In 1953, Danckwerts modeled
non-ideal mixing by measuring the residence time of fluid elements spent inside a
system. Defining RTD, it is specifically a probability distribution function that expresses
the amount of time a fluid element could spend inside a system, providing partial insight
into non-ideal system mixing and dispersion properties. Danckwerts studied the
probability distribution functions in a variety of vessel types and piping, establishing
RTDs to be an operative quantifier of non-ideal mixing in real systems. While useful, a
drawback to RTDs is that the produced function is typically limited to discrete sampling
at the system exit, thus incognizant of characterizing internal happenings (Russ and
Berson, 2016). In effect, an RTD provides no information regarding the spatial
distribution of mixing along the length of a system. While the shape of the produced RTD
function may imply the presence of dead zones in the mixing system, the location of such
vessel areas cannot be determined from an RTD (Liu and Tilton, 2010). This prompts the
desire to understand the spatial distribution of mixing beyond the area of exit and more
internally.
In hopes of extending the topic, Danckwerts reclassified the term “residence time”
for molecules exiting the system as a way to describe the elapsed time since they entered
and developed the concept of “age” to describe the elapsed time since entrance of
molecules still in the system (Liu and Tilton, 2010). Consequently, when a molecule
reaches the exit, its age equals the residence time. As suggested, complete spatial
distributions of age are most valuable, but they are generally unfeasible to develop
experimentally since measurement is required across an entire system volume and
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necessitate tracking the movement of a passive tracer (Russ and Berson, 2016). As a
solution, in recent years, the application of mean age theory has provided an innovative
approach in research associated with spatially resolved mixing. Mean age theory permits
redefining time as a passive scalar in the transient advection-diffusion equation,
facilitating analysis of traditionally time-based variables (e.g., mean residence time)
while using a steady-state solution (Russ and Berson, 2016). Passive scalars may be
thought of as virtual tracers that do not impact flow but are transported by the system as a
way to track flow. While mean age theory was originally proposed by Danckwerts in
1958, technological restraints withheld the topic as strictly theoretical. With the rise of
computational fluid dynamics (CFD), however, spatially resolved solutions for mean age
theory purposes are now possible. While conventional solutions to the advectiondiffusion equation require a time-demanding transient solution for modeling the timedependent tracer behavior, CFD provides robust computing of the transient solution and
the ability to report spatial and temporal resolution within the flow field (Russ and
Berson, 2016).
2. Deriving Mean Age Conservation and the Extension to Multiphase Systems
Mean age theory as an approach to modeling the time-dependent behavior of a
passive scalar in steady-state CFD simulations has been used to determine the mean age
conservation equation plentifully in literature for a single-phase system (Liu and Tilton,
2010; Sandberg, 1981; Spalding, 1958). Russ and Berson (2016) extend the theory for
multiphase systems by defining the passive scalar concentration independently for
individual phases, permitting mean age to be solved at steady-state for each phase
independently within a multiphase system. Liu and Tilton (2010) begin their derivation

23

by defining a spatially resolved concentration 𝐶(𝑥, 𝑡) for the passive scalar at a location 𝑥
and time 𝑡. This concentration function is limited in utility for application, so Russ and
Berson (2016) extend the definition by assuming:
𝐶(𝑥, 𝑡) = 𝜌𝜑(𝑥, 𝑡)

(2.13)

Here, 𝜌 is the density of the single phase and 𝜑(𝑥, 𝑡) is the passive scalar value at a
location 𝑥 and time 𝑡. It follows that the concentration of a passive scalar value for an
individual phase in a multiphase system is:
𝐶(𝑥, 𝑡) = 𝜌𝜑(𝑥, 𝑡)𝛼(𝑥, 𝑡)

(2.14)

Now, 𝜌 is the density of an individual phase and 𝛼(𝑥, 𝑡) is the phasic volume fraction of
an individual phase at a location 𝑥 and time 𝑡. Using these definitions of passive scalar
concentration, the derivation for the mean age conservation equation follows directly
from Liu and Tilton (2010).
Mean residence time for either definition of passive scalar concentration may be
defined as:
𝑡̅ =

∞

∫0 𝑡𝐶𝑜𝑢𝑡 𝑑𝑡
∞

∫0 𝐶𝑜𝑢𝑡 𝑑𝑡

(2.15)

This may then be extended for the spatial distribution of internal happenings by defining
mean age as:
∞

𝑎=

∫0 𝑡𝐶(𝑥,𝑡)𝑑𝑡
∞

∫0 𝐶(𝑥,𝑡)𝑑𝑡

(2.16)

To solve the mean age equation, the transient passive scalar advection-diffusion equation
is used:
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𝜕𝐶
𝜕𝑡

+ ∇ ⋅ (𝑣⃗𝐶) = ∇ ⋅ (𝐷∇𝐶)

(2.17)

In this equation, 𝐷 is the molecular diffusivity. Equation (2.17) and the remaining
derivation steps apply to laminar flow systems. In the case of turbulent flow systems,
Equation (2.17) becomes the Reynolds averaged equation and 𝐷 is replaced by the
effective turbulent diffusivity 𝐷𝑒 , provided that the time scale of turbulence is much
smaller than the scale of mean residence time. If that criterion is met, the remaining
derivation steps for laminar flow systems may be altered for turbulent flow systems by
replacing 𝐷 with 𝐷𝑒 . Multiplication of Equation (2.17) by 𝑡 and integration gives:
∞

∞

𝜕𝐶

∞

∫0 𝑡 𝜕𝑡 𝑑𝑡 + ∫0 ∇ ⋅ (𝑡𝑣⃗𝐶)𝑑𝑡 = ∫0 ∇ ⋅ (𝐷∇(𝑡𝐶))𝑑𝑡

(2.18)

Here, 𝑡 is independent of position and has been brought inside the spatial derivatives. The
first term on the left-hand side of Equation (2.18) may be integrated by parts to give:
∞

∞

𝜕𝐶

∫0 𝑡 𝜕𝑡 𝑑𝑡 = 𝑡𝐶|∞
0 − ∫0 𝐶𝑑𝑡

(2.19)

The first term on the right-hand side of Equation (2.19) will be zero if 𝑡𝐶 is zero in the
limit 𝑡 → ∞. That is, 𝐶 must approach zero faster than 𝑡 approaches infinity, indicating
that the mean age 𝑎 can exist only if 𝑡𝐶 → 0 as 𝑡 → ∞. As such, the first term on the
right-hand side of Equation (2.19) must equal zero so that:
∞

∞

𝜕𝐶

∫0 𝑡 𝜕𝑡 𝑑𝑡 = − ∫0 𝐶𝑑𝑡

(2.20)
∞

Substitution of Equation (2.20) into Equation (2.18) and division by ∫0 𝐶𝑑𝑡 gives:
∫

∞

𝑡𝐶𝑑𝑡

−1 + ∇ ⋅ {𝑣⃗ [ 0∞

∫0 𝐶𝑑𝑡

∞

∫ 𝑡𝐶𝑑𝑡

]} = ∇ ⋅ {𝐷∇ [ 0∞

∫0 𝐶𝑑𝑡
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]}

(2.21)

Lastly, substituting the definition of 𝑎 (Equation (2.16)), the general conservation
equation for mean age is:
∇ ⋅ (𝑣⃗𝑎) = ∇ ⋅ (𝐷∇𝑎) + 1

(2.22)

Equation (2.22) may be simplified for incompressible flow in single-phase systems to
give:
𝑣⃗ ⋅ ∇𝑎 = ∇ ⋅ (𝐷∇𝑎) + 1

(2.23)

Equation (2.22) mirrors the same form as the conservation equations of mass and
momentum, enabling solution by the same CFD solver. It is noted that both definitions of
𝐶(𝑥, 𝑡) produce the same conservation equation, so mean age theory is now presently
extended from single-phase to multiphase systems. Liu and Tilton (2010) derive
boundary conditions for the conservation equation for mean age and are based on tracer
concentration. Utilizing Equation (2.16) and the normal coordinate in the flow direction
𝑥𝑛 , Liu and Tilton (2010) show that suitable boundary conditions for Equations (2.22)
and (2.23) are:
𝑎 = 0, at inlet
𝜕𝑎

𝑛̂ ⋅ ∇𝑎 = 𝜕𝑥 = 0, on solid walls
𝑛

𝜕𝑎

𝑛̂ ⋅ ∇𝑎 = 𝜕𝑥 = 0, at outlet
𝑛

(2.24)
(2.25)

(2.26)

Russ and Berson (2016) show that multiphase mean age theory is well validated
by comparing experimental RTDs obtained from spatial mean age distributions to ones
found computationally at two locations in the same water-oil flow system. Mean RTD
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values and variances from multiphase mean age theory were within 1–3% and 3–11%,
respectively, of experimental values. With this, mean RTD values and variances derived
from multiphase mean age theory neared experimental values more closely than
respective values derived from conventional transient solutions, indicating the innate
steady-state solution associated with the theory increased the accuracy (Russ and Berson,
2016). Multiphase mean age theory is applicable to systems of any phase type, and since
steady-state solutions are utilized, the theory is valuable for systems with lengthy
residence times or ages.
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III. EXPERIMENTAL METHODS
A. Preliminaries
1. Purpose
The purpose of this investigation was to utilize CFD and multiphase mean age
theory as a way to compare a novel mean age metric determined from two-dimensional
arterial slices with those that are used to detect and assess a stenotic artery determined
from corresponding three-dimensional arterial renderings. Using supercomputing,
calculations can approach a total duration on the order of days to simulate multiphase
flow in a typical three-dimensional segment of an artery. Comparatively, simulating flow
in a two-dimensional slice of the same segment takes on the order of about 60 minutes. If
two-dimensional slicing can produce a similar mean age metric to its three-dimensional
source, the more easily-processed, two-dimensional slices may be preferentially chosen
to aid in long-term three-dimensional correlative approaches to 𝐹𝐹𝑅.
2. Plan
Two-dimensional arterial slices were generated from the three-dimensional source
arteries using the computer-aided design software packages of ANSYS SpaceClaim and
Dassault Systèmes SolidWorks. To better capture a wider range of the three-dimensional
geometries, two orthogonal slices were created within each artery, giving two sets of ten
(or 20 slices in total) to process. SpaceClaim was used to create two separate STEP files
representing the three-dimensional arterial outlines, while SolidWorks was used to
convert the outlines to two-dimensional surface entities via filling, flattening, and
aligning. ANSYS Meshing was then used to create a discretized domain of a geometric
mesh of at least 20,000 elements on the slices. Following this, ANSYS Fluent was used
28

to simulate pulsing blood flow and to calculate the mean ages of the plasma and red
blood cell phases using user-defined scalars. From this, the mean ages of the twodimensional slices were compared to nominal mean residence times to characterize the
age impact of an occurring stenosis. Finally, the mean ages of the two-dimensional slices
were then compared to respective three-dimensional mean age values of the source
renderings for final assessment.
B. Materials
A Lenovo ThinkPad with an Intel Core i5-3320M CPU @ 2.60 GHz was used to
run the ANSYS 17.1 software packages of Workbench, SpaceClaim, Meshing, and
Fluent on Windows 7. With this, a MacBook Pro with an Intel Core i5-6267U CPU @
2.90 GHz was used in conjunction with Parallels Desktop for Mac to run Dassault
Systèmes SolidWorks on Windows 10.
DICOM-derived, three-dimensional STL files of arteries rendered by coronary
angiograms were provided for slicing treatment. User-defined function (UDF) files were
used to generate pulsing at the boundaries. Each UDF differs by multiplicative constants
on the piecewise functions of Equations 3.1 and 3.2:
𝑣𝑖𝑛𝑙𝑒𝑡 = {

0.1,
0.26 sin(1.58𝜋(𝑡 + 0.92)),

𝑝𝑜𝑢𝑡𝑙𝑒𝑡 = {

18665.13 sin(1.4𝜋(0.8𝑡 + 0.1305)) ,
−13400𝑡 + 22700,

0 < 𝑡 ≤ 0.42
0.42 < 𝑡 ≤ 0.9

(3.1)

0 < 𝑡 ≤ 0.42
0.42 < 𝑡 ≤ 0.9

(3.2)

Sample source code for a UDF file may be seen in APPENDIX I.
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C. Procedures for Processing Two Orthogonal Arterial Slices
1. Geometry Generation
Arterial slice geometry was generated using ANSYS Workbench and the two
computer-aided design software packages of ANSYS SpaceClaim and Dassault Systèmes
SolidWorks. The following steps describe how to create arterial slices from threedimensional arteries:
a. SpaceClaim.

SpaceClaim was used to create two separate STEP files

representing the three-dimensional arterial outlines.
i. New Geometry Module and SpaceClaim File. Open Workbench and
drag a new Geometry module from the Toolbox pane to the Project
Schematic pane. Right-click the Geometry module and click “New
SpaceClaim Geometry...” to open SpaceClaim.
ii. Opening the STL File. Click File → Open and navigate to the threedimensional STL file. Before opening the file, click “Options...” in the
Open window and ensure the settings highlighted in FIGURE 3.1 are
followed:
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FIGURE 3.1 - STL File Opening Settings in SpaceClaim
Click “OK” in the SpaceClaim Options window and click “Open” in the
Open window to import the three-dimensional geometry. Importantly,
the geometry will have boundaries of a single face nearly circular in
shape, while the wall will be composed of hundreds of faces of various
shape.
iii. Line Creation. Orthogonal markers are needed on both boundary faces
to guide slice creation. To create orthogonal markers, choose Line from
the ribbon. Under the Options - Sketch pane on the left, ensure the
options highlighted in FIGURE 3.2 are followed:
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FIGURE 3.2 - Line Options in SpaceClaim
With Line selected from the ribbon, a grid will display on the drawing
space. Move the cursor to a boundary face so that the grid displays
major axes on it. FIGURE 3.3 displays this:

FIGURE 3.3 - Major Axes Displayed on a Boundary Face in
SpaceClaim
Zooming in, draw two orthogonal lines on a boundary face that extend
beyond the length of the face. The grid should be used to snap the lines
and ensure orthogonality. FIGURE 3.4 displays this:
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FIGURE 3.4 - Two Orthogonal Lines Extending Beyond a Boundary
Face in SpaceClaim
With the two lines now extending beyond a boundary face, the lines
must be reduced to the constraints of the face itself. Click Select from
the ribbon and choose one of the four line endpoints. Using a
combination of zooming and panning, hold the Shift key and drag the
endpoint to the extent of the associated boundary face. Repeat this
process for the remaining three endpoints so that the lines match that of
FIGURE 3.5:

FIGURE 3.5 - Two Orthogonal Lines Reduced to the Extent of a
Boundary Face in SpaceClaim
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Rotating the object so that the other boundary face is visible, repeat this
process of line creation on it. It is noted that the major axes used for the
first face will be presented by default on the second face, and this
ensures respective “horizontal” and “vertical” lines are kept similar. In
total, four lines should be created. Alike lines from both faces serve as
the boundary lines for the arterial slices. For organizational purposes,
right-click the lines in the Structure pane and rename alike lines as
Line1_1 and Line1_2 for Slice 1 and as Line2_1 and Line2_2 for Slice
2. The distribution of names is shown in FIGURE 3.6, where the threedimensional object has been suppressed from visibility to make line
discernment easier:

FIGURE 3.6 - Line Name Distribution in SpaceClaim
It is also noted here that the lines ending in “_1” denote what will
eventually become inlet boundaries. The designation of inlet and outlet
boundaries stems from choosing the face with the larger surface area to
be the inlet.
iv. Spline Creation. Splines are needed on the wall of the artery to create an
outline for both slices. To create splines, choose Spline from the ribbon.
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SpaceClaim defaults to two-dimensional creation, so type the D key to
activate three-dimensional space control. Begin a spline creation by
clicking the intersection point between a line created in iii and the
perimeter of a boundary face. Using a combination of rotating, zooming,
and panning, click points along the length of the wall of the artery until a
connection is made to the alike line/boundary intersection. The initial
creation of a spline is shown in FIGURE 3.7:

FIGURE 3.7 - Initial Spline Creation in SpaceClaim
The completed spline extending the length of the artery is shown in red
in FIGURE 3.8:

FIGURE 3.8 - Completed Spline (in Red) in SpaceClaim
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Again, connection must be made to the respective line on the other end
of the artery. Viewing FIGURE 3.7, it is clear that the arterial wall is
composed of numerous faces. Splines snapping to the edges of these
faces provides a difficulty in creating connections that stay consistent
with the curvature of the geometry. Special care in guaranteeing
acceptable spacing between clicked points must be taken to ensure an
adequate connection between boundary lines is made. Rotating the
object so that the other line/boundary intersections are visible, repeat this
process of spline creation. In total, four splines should be created that are
nearly equally spaced and form a frame of the artery. Alike splines from
the same axis serve as the wall for the arterial slices. For organizational
purposes, right-click the splines in the Structure pane and rename alike
splines as Spline1_1 and Spline1_2 for Slice 1 and as Spline2_1 and
Spline2_2 for Slice 2. Using red and green, the distribution of names is
shown in FIGURE 3.9, where the three-dimensional object has been
suppressed from visibility to make spline discernment easier:

FIGURE 3.9 - Spline Name Distribution in SpaceClaim
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It is noted that the outlines for each slice are now created. It is
recommended to click File → Save As and save as a SpaceClaim file to
create a file checkpoint to start from should downstream issues arise.
v. Saving As a STEP File. The outlines of the two slices must be saved
individually for proper analysis hereafter. To begin the process of saving
the first slice outline, delete all geometry in the Structure pane aside
from the two lines and two splines outlining a slice. For example, to
isolate the outline of Slice 1, right-click and delete the arterial body
denoted as Solid, Line2_1, Line2_2, Spline2_1, and Spline2_2 in the
Structure pane. In doing so, the outline for Slice 1 should be solely
present. FIGURE 3.10 displays the Structure pane (a) before and (b)
after deletion of Slice 2 components:

(a)

(b)

FIGURE 3.10 - Structure Pane (a) Before and (b) After Deletion of Slice
2 Components in SpaceClaim
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In performing the above deletions, the only remaining components of
geometry are those which outline Slice 1, and this is shown in FIGURE
3.11:

FIGURE 3.11 - Components of Geometry Outlining Slice 1 After
Deletion of Slice 2 Components in SpaceClaim
With only the outline of Slice 1 present, click File → Save As. In the
Save As window, ensure the options highlighted in FIGURE 3.12 are
followed:

FIGURE 3.12 - Save As Window and Options for STEP File Creation in
SpaceClaim
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Click “Save” in the Save As window to create a three-dimensional STEP
file for Slice 1. Finally, the saving process must be repeated for Slice 2.
With SpaceClaim still open, undo the previous deletion of Slice 2
geometry (returning to file checkpoint) and invert the components to be
deleted and delete them. Accordingly, to isolate the outline of Slice 2,
right-click and delete the arterial body denoted as Solid, Line1_1,
Line1_2, Spline1_1, and Spline1_2 in the Structure pane. In doing so,
the outline for Slice 2 should be solely present. Repeat the Save As steps
represented by FIGURE 3.12 to create a STEP file for Slice 2. Two
separate STEP files representing the three-dimensional arterial outlines
have been created and are in position for SolidWorks treatment.
b. SolidWorks. SolidWorks was used to convert the three-dimensional arterial
outlines to two-dimensional surface entities via filling, flattening, and aligning.
i. New SolidWorks File.

Open SolidWorks. Click File → Open and

navigate to one of the three-dimensional arterial outline STEP files
created in SpaceClaim. Click “Open” in the Open window to import the
three-dimensional geometry. Importantly, the geometry is a threedimensional outline in position for two-dimensional surface conversion
via filling, flattening, and aligning.
ii. Filling the Outline. Choose Filled Surface from the ribbon. With the
blue Patch Boundary box highlighted in blue, select the geometric
outline. The three-dimensional outline will fill to create a surface, which
is shown in process in FIGURE 3.13:
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FIGURE 3.13 - Fill Surface Pane Magnified and the Three-Dimensional
Outline Being Filled in SolidWorks
Click the green checkmark under the Fill Surface pane on the left to
confirm the filling.
iii. Flattening the Three-Dimensional Surface. Choose Surface Flatten from
the ribbon. With the blue Face/Surface to Flatten box highlighted blue,
select the surface. With the pink Vertex or Point on Edge to Flatten
From box highlighted blue, select one of two boundary lines. Finally,
click and drag the Accuracy handle to High. The three-dimensional
surface will flatten to create a two-dimensional surface, which is shown
in process in FIGURE 3.14:
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FIGURE 3.14 - Flatten Pane Magnified and the Three-Dimensional
Surface Being Flattened in SolidWorks
Click the green checkmark under the Flatten pane on the left to confirm
the flattening.
iv. Aligning the Surface.

Click Insert → Surface → Move/Copy... to

initiate the aligning process. With the Bodies to Move box highlighted in
blue, select the flattened surface. With Mate Settings box highlighted
blue, select the flattened surface and the default Front Plane. Ensure
Coincident is chosen below the Mate Settings box. The flattened surface
will align to the XY-plane, which is shown in process in FIGURE 3.15:
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FIGURE 3.15 - Move/Copy Body Pane Magnified and the TwoDimensional Surface Being Aligned in SolidWorks
Click the green checkmark under the Move/Copy Body pane on the left
to confirm the aligning.
v. Deleting the Three-Dimensional Surface. Two objects are visible at this
point, but the remaining three-dimensional surface must be deleted.
Opening the Surface Bodies folder in the hierarchy pane, right-click the
filled surface and click Delete/Keep Body... to open the Delete/Keep
Body... pane. Ensure the Delete/Keep Body... pane shows Delete Bodies
under Type and the Bodies to delete box highlighted in blue shows the
filled surface. This process is shown in FIGURE 3.16:
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FIGURE 3.16 - Delete/Keep Body... Pane Magnified and the ThreeDimensional Surface Being Deleted in SolidWorks
Click the green checkmark under the Delete/Keep Body... pane on the
left to confirm the deletion. Only a two-dimensional slice oriented on the
XY-plane remains.
vi. Saving As a STEP File. The two-dimensional slice must be saved as a
STEP file for proper analysis hereafter. Click File → Save As. In the
Save As window, ensure the STEP AP203 file format is chosen. Click
“Save” in the Save As window to create a two-dimensional STEP file
for Slice 1.
vii. Repeat for Slice 2. Repeat the above steps in the SolidWorks subsection
for the three-dimensional Slice 2 STEP file generated from SpaceClaim.
As a result, two separate STEP files representing the filled, flattened,
and aligned two-dimensional arterial slices have been created and are in
position for Meshing treatment.
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2. Mesh Generation
The two generated arterial slices were meshed using the software of ANSYS
Meshing. The following steps describe how to create a suitable mesh:
a. Preliminary Setup.

Workbench and Meshing are used to structure the

introductory arrangement of mesh generation.
i. New Fluid Flow (Fluent) Module and Importing the Geometry File. In
Workbench, drag a new Fluid Flow (Fluent) module from the Toolbox
pane to the Project Schematic pane. This module is added next to the
previously inserted Geometry module. FIGURE 3.17 displays the
Project Schematic setup:

FIGURE 3.17 - Project Schematic Pane with Geometry and Fluid Flow
(Fluent) Modules in Workbench
To import the proper geometry, right-click the Geometry cell in the
Fluid Flow (Fluent) module and click Import Geometry → Browse... and
browse to one of the two-dimensional arterial slice STEP files created in
SolidWorks. Click “Open” in the Open window. A green checkmark
will display in the Geometry cell to confirm the importing.
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ii. Initial Meshing Preferences.

Open Meshing by double-clicking the

Mesh cell in the Fluid Flow (Fluent) Module. In Meshing, click Mesh
from the Outline pane on the left. The Details of “Mesh” pane will
display under the Outline pane. In the Details of “Mesh” pane, ensure
Fluent is chosen as the Solver Preference under the Defaults group. In
the same pane, choose “Proximity and Curvature” for Size Function and
“Fine” for Relevance Center under the Sizing group. These preferences
are highlighted in FIGURE 3.18:

FIGURE 3.18 - Details of “Mesh” Pane Preferences in Meshing
b. Meshing Controls. Controls must be applied to construct a working mesh.
i. Body Sizing. Right-click Mesh from the Outline pane and click Insert.
FIGURE 3.19 displays the Insert controls:
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FIGURE 3.19 - Insert Controls in Meshing
Click Sizing. The Details of “Mesh” pane will convert to the Details of
“Sizing” - Sizing pane. Geometry under the Scope group will display No
Selection. To select the proper geometry, click the green Body tool from
the ribbon and select the slice in the Geometry space. The slice will turn
green. In the Details of “Sizing” - Sizing pane, click Apply for
Geometry under the Scope group. FIGURE 3.20 displays the resulting
pane, which converts to “Body Sizing” after clicking Apply:

FIGURE 3.20 - Details of “Body Sizing” - Sizing Pane in Meshing
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Importantly, Geometry under the Scope group displays “1 Body,”
confirming proper selection has been made.
ii. Inflation.

Right-click Mesh from the Outline pane again and click

Insert. As seen in FIGURE 3.19, click Inflation. Geometry under the
Scope group and Boundary under the Definition group will display No
Selection. To select the proper geometry, click the green Face tool from
the ribbon and select the slice face in the Geometry space. The slice face
will turn green. In the Details of “Inflation” - Inflation pane, click Apply
for Geometry under the Scope group. In a similar manner, click the
green Edge tool from the ribbon and select the two wall edges of the
slice in the Geometry space. The two wall edges of the slice will turn
green. In the Details of “Inflation” - Inflation pane, click Apply for
Boundary under the Definition group. With this, change the number of
inflation layers to “10” by toggling to the number for Maximum Layers
under the Definition group. FIGURE 3.21 displays the resulting pane:

FIGURE 3.21 - Details of “Inflation” - Inflation Pane in Meshing
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Importantly, Geometry under the Scope group displays “1 Face,”
Boundary under the Definition group displays “2 Edges,” and the
Maximum Layers under the Definition group displays 10, confirming
proper selections and settings have been made.
iii. Named Selections.

For downstream Fluent processing, Named

Selections must be applied to the inlet, outlet, wall, and interior of the
slice. To define the inlet, begin by clicking the green Edge tool from the
ribbon and selecting the larger of the two boundary edges. Right-click
and choose Create Named Selection. Name the selection as inlet in the
Selection Name window, ensure Apply selected geometry is ticked, and
click “OK.” FIGURE 3.22 displays the process of creating a Named
Selection for the inlet:

FIGURE 3.22 - Creating a Named Selection for the Inlet in Meshing
Repeat the process for the outlet, wall, and interior. The outlet is the
other boundary edge, while the wall is defined by the same wall edges as
in the Inflation steps. The interior is the face of the slice, and it is named
“artery” for clarity. This, and the remaining distribution of color-coded
Named Selections, is shown in FIGURE 3.23:
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FIGURE 3.23 - Named Selection Distribution in Meshing
c. Processing and Requirements.

Proper processing to achieve set mesh

requirements must occur to create a final mesh suitable for downstream use.
i. Mesh Construction and Mesh Count. Begin the meshing process by
clicking Generate Mesh at the top of the ribbon. After processing, click
Show Mesh at the top of the ribbon to display the mesh. Upon
inspection, inflation layers line the wall and a mesh has been created, but
the mesh count must be checked for acceptable resolution. To begin the
check, click Mesh from the Outline pane on the left. The Details of
“Mesh” pane will display under the Outline pane. In the Details of
“Mesh” pane, review Elements under the Statistics group. This is
highlighted in FIGURE 3.24:
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FIGURE 3.24 - Checking Mesh Count in the Details of “Mesh” Pane in
Meshing
The number associated with Elements represents the mesh count. This
value should be no less than 20,000. The mesh count is increased by
decreasing the Element Size under the Definition section in the Details
of “Body Sizing” - Sizing pane, which is seen in FIGURE 3.20.
Typically, an Element Size of 0.10 mm will produce a mesh count near
20,000. After changing the Element Size value in FIGURE 3.20, click
Generate Mesh again, inspect the mesh using Show Mesh, and check the
mesh count in the Details of “Mesh” Pane for a value of at least 20,000.
ii. Repeat for Slice 2. Repeat the above steps in the Mesh Generation
subsection for the other two-dimensional arterial slice STEP file created
in SolidWorks. As a result, two separate modules containing the meshed
slices have been created and are in position for Fluent treatment.
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3. Fluent Case Processing
Blood flow through the two meshed arterial slices was simulated using the
software of ANSYS Fluent. The following steps describe how to run a suitable case:
a. Preliminary Setup.

Workbench is used to structure the introductory

arrangement of Fluent cases.
i. Opening Fluent Launcher and Fluent. In Workbench, double-click the
Setup cell in the previously inserted Fluid Flow (Fluent) Module. Fluent
Launcher will open. Verify that the default settings restrict 2D for
Dimension, and ensure the setting highlighted in FIGURE 3.25 is
followed:

FIGURE 3.25 - Fluent Launcher Window in Workbench
Click “OK” to open Fluent.
b. Setup. The Setup group in the Tree hierarchy arranges the most common
system setup tasks.
i. General. Click General in the Tree hierarchy to display the General
pane, and ensure the settings highlighted in FIGURE 3.26 are followed:
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FIGURE 3.26 - General Pane in Fluent
ii. Models. Click Models in the Tree hierarchy to display the Models pane,
and select Multiphase - Off. To activate this model, click “Edit...” at the
bottom of the Models pane. The Multiphase Model window will open,
where the settings highlighted in FIGURE 3.27 should be applied:

FIGURE 3.27 - Multiphase Model Window in Fluent
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Click “OK” to activate the model. In the Models pane, activation is
complete if the model displays “Multiphase - Eulerian.” With this,
ensure that the Viscous model displays the default “Viscous - Laminar.”
iii. Materials. Click Materials in the Tree hierarchy to display the Materials
pane. Default fluid and solid materials of air and aluminum,
respectively, will be present. Air will be replaced with the two phases of
plasma and red blood cells, while aluminum will be kept unchanged.
With Fluid highlighted, click “Create/Edit...” at the bottom of the
Materials pane. The Create/Edit Materials window will open, where the
settings highlighted in FIGURE 3.28 for plasma should be applied:

FIGURE 3.28 - Create/Edit Materials Window for Plasma in Fluent
In FIGURE 3.28, a density of 1,003 kg m-3 is used, and a viscosity of
0.001 kg m-1 s-1 is used. Similar steps may be taken to define red blood
cells as a material. For red blood cells, however, a density of 1,096 kg
m-3 is used, and viscosity is inserted by changing its drop-down to “userdefined” and clicking “Edit...” to the right of it. The car_yas_visc option
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is chosen as the viscosity in the User-Defined Functions window, as
shown in FIGURE 3.29:

FIGURE 3.29 - User-Defined Functions Window with car_yas_visc
Viscosity Selection for Red Blood Cells in Fluent
Click “OK” to activate the model, and click “Close” in the Create/Edit
Materials window. It is noted that the car_yas_visc option will only be
available after a user-defined function is interpreted, as in FIGURE 3.33.
iv. Defining Phases. Phases are defined by clicking List/Show All... above
Phases under the Setting Up Physics tab in the ribbon. The Phases
window will open, as shown in FIGURE 3.30:

FIGURE 3.30 - Phases Window in Fluent
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Ensure the primary (phase-1) and secondary (phase-2) phases are plasma
and red blood cells, respectively, by clicking “Edit...” and choosing the
proper material from the Phase Material drop-down. Red blood cells
require additional settings for phasic definition. As such, enable
Granular in the Secondary Phase window to reveal property input. This
is shown in FIGURE 3.31, where the highlighted settings should be
applied:

(a)

(b)

FIGURE 3.31 - Secondary Phase Window in (a) General and with the
(b) Granular Properties Magnified in Fluent
Phasic interaction settings are changed by clicking “Interaction...” at the
bottom of the Phases window seen in FIGURE 3.30. Interaction changes
for virtual mass, lift, collisions, mass, surface tension, and interfacial
area are available, but the drag coefficient is the only item in need of
modification. Keeping all other interactions default, FIGURE 3.32
displays the highlighted setting to be changed for the drag coefficient:
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(a)

(b)

FIGURE 3.32 - Phase Interaction Window in (a) General and with the
(b) Drag Coefficient Settings Magnified in Fluent
v. Interpreting a User-Defined Function and Setting User-Defined Scalars.
To permit use of scalars, a user-defined function must first be read by
Fluent. Click Functions → Interpreted... above User-Defined under the
User-Defined tab in the ribbon. The Interpreted UDFs window will
open. Click Browse... and locate the proper source code file. The
resulting window is shown in FIGURE 3.33:

FIGURE 3.33 - Interpreted UDFs Window in Fluent
Click “Interpret” in the Interpreted UDFs window and then click
“Close.” With this, scalar definition begins by clicking Scalars... above
User-Defined under the User-Defined tab in the ribbon. The User56

Defined Scalars window will open, where the settings highlighted in
FIGURE 3.34 should be applied:

(a)

(b)

FIGURE 3.34 - User-Defined Scalars Window for (a) Red Blood Cells
and (b) Plasma in Fluent
Click “OK” to confirm the addition of the two scalars. Viewing
FIGURE 3.34, it is stated that phase-2 now represents red blood cells
and Scalar0, while phase-1 now represents plasma and Scalar1.
vi. Mean Ages of the Phases Using User-Defined Scalars - Scalar0. It is
initially noted that this subsection demonstrates the steps necessary for
mean age calculation setup with respect to Scalar0, with analogous
images of Scalar1 setup displayed in the succeeding subsection.
Recognizing this, the material properties of red blood cells must be
updated to reflect scalar impact. Reopen the Create/Edit Materials
window for red blood cells, which will now include the UDS Diffusivity
option highlighted in FIGURE 3.35:
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FIGURE 3.35 - Updated Create/Edit Materials Window for Scalar0 in
Fluent
UDS diffusivity is inserted by changing its drop-down to “defined-peruds” and clicking “Edit...” to the right of it. A coefficient is entered in
the UDS Diffusion Coefficients window, as shown highlighted in
FIGURE 3.36:

FIGURE 3.36 - UDS Diffusion Coefficients Window for Scalar0 in
Fluent
Click “OK” to confirm the coefficient, and click “Change/Create” and
then “Close” in the Create/Edit Materials window. With this, to apply
the scalar to the proper zone of geometry, click Cell Zone Conditions in
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the Tree hierarchy to display the Cell Zone Conditions pane. With the
phase of red blood cells (phase-2) chosen in the Phase drop-down in the
pane, click “Edit...” to open the Fluid window. Enable Source Terms and
click “Edit...” to the right of User Scalar 0 under the Source Terms tab.
This will open the User Scalar 0 sources window. The same magnitude
of density for red blood cells used previously (1,096) should be entered
as the constant value. This process, with proper settings highlighted, is
shown in FIGURE 3.37:

FIGURE 3.37 - Fluid and User Scalar 0 Sources Windows for Scalar0 in
Fluent
Click “OK” in both windows to confirm scalar zone application. Finally,
to apply the scalar in the boundary conditions, click Boundary
Conditions in the Tree hierarchy to display the Boundary Conditions
pane. With phase-2 still chosen in the Phase drop-down in the pane,
select the inlet boundary and click “Edit...” to open the Velocity Inlet
window. Three tabs of options are available, and the settings to be
changed are shown highlighted in FIGURE 3.38:
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(a)

(b)

(c)

FIGURE 3.38 - Velocity Inlet Window for Scalar0 Displaying (a)
Momentum, (b) Multiphase, and (c) UDS Settings in Fluent
Click “OK” to confirm the inlet boundary condition. With phase-2 still
chosen in the Phase drop-down in the Boundary Conditions pane, select
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the outlet boundary and click “Edit...” to open the Pressure Outlet
window. Two tabs of options are available, and the default settings to
ensure are shown in FIGURE 3.39:

(a)

(b)

FIGURE 3.39 - Pressure Outlet Window for Scalar0 Displaying (a)
Multiphase and (b) UDS Settings in Fluent
Click “OK” to confirm the outlet boundary condition.
vii. Mean Ages of the Phases Using User-Defined Scalars - Scalar1. While
previous steps have defined the scalar for red blood cells, similar steps
may be taken for scalar definition of plasma. FIGURES 3.40–44 display
Scalar1 analogs of the preceding steps of Scalar0 definition:
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FIGURE 3.40 - Updated Create/Edit Materials Window for Scalar1 in
Fluent

FIGURE 3.41 - UDS Diffusion Coefficients Window for Scalar1 in
Fluent

FIGURE 3.42 - Fluid and User Scalar 1 Sources Windows for Scalar1 in
Fluent
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(a)

(b)

FIGURE 3.43 - Velocity Inlet Window for Scalar1 Displaying (a)
Momentum and (b) UDS Settings in Fluent

FIGURE 3.44 - Pressure Outlet Window for Scalar1 Displaying UDS
Settings in Fluent
63

c. Solution. The Solution group in the Tree hierarchy arranges solution setup and
calculation task direction.
i. Solution Methods. Click Solution Methods in the Tree hierarchy to
display the Solution Methods pane, and ensure the settings highlighted
in FIGURE 3.45 are followed:

FIGURE 3.45 - Solution Methods Pane in Fluent
ii. Solution Controls. Click Solution Controls in the Tree hierarchy to
display the Solution Controls pane, and ensure the settings highlighted in
FIGURE 3.46 are followed:
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(a)

(b)

FIGURE 3.46 - Solution Controls Pane in (a) General and with the (b)
Under-Relaxation Factors Magnified in Fluent
It is noted that the value of User Scalar 0 shown in FIGURE 3.46(b) may
need infrequent reduction if divergence errors emerge. As such, this
value may be halved until divergence is mitigated and a solution is
calculated.
iii. Monitors. Click Monitors in the Tree hierarchy to display the Monitors
pane. Select Residuals - Print, Plot under Residuals, Statistic and Force
Monitors in the pane, and click “Edit...” below it. The Residual Monitors
window will open, where the settings highlighted in FIGURE 3.47
should be applied:
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(a)

(b)

FIGURE 3.47 - Residual Monitors Window in (a) General and with the
(b) Equations Magnified in Fluent
Click “OK” to confirm the residual monitor settings.
iv. Solution Initialization.

Click Solution Initialization in the Tree

hierarchy to display the Solution Initialization pane. With Hybrid
Initialization chosen from the Initialization Methods options, click
“Initialize.” Appropriate starting values are generated for necessary
system components, but the initial zero values of the scalars must be
changed manually to further assist in solution convergence. As such,
select Standard Initialization from the Initialization Methods options,
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and apply the nonzero values highlighted in FIGURE 3.48 for the
scalars:

(a)

(b)

FIGURE 3.48 - Solution Initialization Pane in (a) General and with the
(b) Initial Values Magnified in Fluent
Click “Initialize” again to prime the system for solution calculation.
v. Run Calculation. Click Run Calculation in the Tree hierarchy to display
the Run Calculation pane, where the settings highlighted in FIGURE
3.49 should be applied:
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FIGURE 3.49 - Run Calculation Pane in Fluent
Click “Calculate” to begin solution calculation.
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IV. RESULTS AND DISCUSSION
A. Scope of Investigated Patient Numbers, Source Renderings, and Created Slices
Results are presented for 10 patient cases, five below and five above the 𝐹𝐹𝑅
threshold of 0.80 reported by Min et al. (2015) as the value below which a cardiologist
intervenes with stent placement to prevent ischemia. The 10 patient cases are listed in
TABLE 4.1:
TABLE 4.1
VALUES OF 𝐹𝐹𝑅 AND COMPONENTS OF THE ARTERIAL TREE
REPRESENTING THE PATIENT NUMBERS USED IN THIS INVESTIGATION
Patient
Number
004
005
017
019
041
045
046
058
061
075

𝑭𝑭𝑹
0.76
0.75
0.72
0.76
0.70
0.83
0.98
0.98
0.97
0.81

Arterial Tree Component
mid left anterior descending
mid right coronary
left anterior descending
posterior descending
proximal left anterior descending
mid left anterior descending
distal right coronary
proximal left circumflex
mid right coronary
mid left anterior descending

“low”

“high”

The three-dimensional source renderings of low and high 𝐹𝐹𝑅 used for two-dimensional
slicing are shown, respectively, in FIGURES 4.1–5 and FIGURES 4.6–10:
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(a)

𝐹𝐹𝑅: 0.76

(b)

(c)

FIGURE 4.1 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 004
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(a)

𝐹𝐹𝑅: 0.75

(b)

(c)

FIGURE 4.2 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 005
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(a)

𝐹𝐹𝑅: 0.72

(b)

(c)

FIGURE 4.3 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 017
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(a)

𝐹𝐹𝑅: 0.76

(b)

(c)

FIGURE 4.4 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 019
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(a)

𝐹𝐹𝑅: 0.70

(b)

(c)

FIGURE 4.5 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 041
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(a)

𝐹𝐹𝑅: 0.83

(b)

(c)

FIGURE 4.6 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 045
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(a)

𝐹𝐹𝑅: 0.98

(b)

(c)

FIGURE 4.7 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 046
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(a)

𝐹𝐹𝑅: 0.98

(b)

(c)

FIGURE 4.8 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 058
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(a)

𝐹𝐹𝑅: 0.97

(b)

(c)

FIGURE 4.9 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 061
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(a)

𝐹𝐹𝑅: 0.81

(b)

(c)

FIGURE 4.10 - Depictions of the (a) Three-Dimensional Source Rendering and TwoDimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 075
Fluent was used to simulate pulsing blood flow in each of the depictions shown in
FIGURES 4.1–10 and to calculate the mean ages of the plasma and red blood cell phases
using user-defined scalars. With Scalar1 representing plasma and Scalar0 representing
red blood cells, it is noted that only Scalar0 results are presented in this section. Since
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plasma is believed to behave more as a continuous phase within blood, its flow may be
less impacted by a stenosis than the fluid’s red blood cells. While red blood cells are not
strictly granular, the granular method of modeling used for red blood cells is an attempt
to create a simplified model of collision at a constriction within an artery. In using this
setup, the red blood cell phase provides mean age data that the continuous, unaffecting
plasma phase simply cannot. These data are shown in subsequent plots of Scalar0 mean
age. For completeness, however, plots of Scalar1 mean age may be seen in APPENDIX
II.
B. Fluent Results of the Three-Dimensional Source Renderings
Fluent was used to simulate pulsing blood flow in the three-dimensional source
renderings while tracking a user-defined scalar (Scalar0), representing the mean age of
red blood cells, over the duration of flow. The plots displayed in this subsection
subsequently represent the mean age of red blood cells as a function of elapsed flow time.
Plots of Scalar0 mean age typically resemble periodic behavior as a result of the pulsing
boundary conditions. Increased peaks of mean age varying from standard periodicity,
however, are indicators of stenotic character along the flow path as blood attempts to
transport from inlet to outlet but is impeded. In other words, an increase in mean age is
attributed to an obstructing stenosis. With this, the plots utilize area-weighted averaging
of the scalar value instead of mass-weighted averaging. Mean age itself is a calculation of
the average time of all material passing through a given location rather than the average
time of all material wherever it may be in the system. As a result, area-weighted average
is more relevant than mass-weighted averaging for the three-dimensional source
rendering systems.
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Area-Weighted Average
of Scalar0

The five cases of low 𝐹𝐹𝑅 are shown in FIGURES 4.11–15:
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FIGURE 4.11 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
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FIGURE 4.12 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
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FIGURE 4.13 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
Rendering of Patient 017
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FIGURE 4.14 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
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FIGURE 4.15 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
Rendering of Patient 041
As shown, each of the five low 𝐹𝐹𝑅 source renderings exhibit an increased peak of
significantly large magnitude. The appearance of high peaks may be attributed to stenotic
character present within a source rendering. With this, patients of lower 𝐹𝐹𝑅 value are
observed to provide the highest elevation in peak. This is to say that Patient 041, with its
𝐹𝐹𝑅 value of 0.70, displays the highest peak value, while Patients 004 and 019, with
their 𝐹𝐹𝑅 value of 0.76, exhibit the lowest increase in mean age. These results align with
the expectations associated with an 𝐹𝐹𝑅 value below 0.80 impacting an artery.
The five cases of high 𝐹𝐹𝑅 are shown in FIGURES 4.16–20:
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FIGURE 4.16 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
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FIGURE 4.17 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
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FIGURE 4.18 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
Rendering of Patient 058
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FIGURE 4.19 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
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FIGURE 4.20 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source
Rendering of Patient 075
As shown, three of the five high 𝐹𝐹𝑅 source renderings (i.e., those from Patients 045,
046, and 058) exhibit the beginnings of periodicity and/or a slight peak of mean age
value. As a whole, these source renderings align with the expectations governed by a high
𝐹𝐹𝑅 value, which are expressed by their generally low mean age values. With this,
however, there are increasingly elevated peaks present in the plots for Patients 061 and
075. Nevertheless, these peaks do not reach the same magnitudes of elevation as shown
in renderings of low 𝐹𝐹𝑅 value, and these increased peaks of mean age may be attributed
to natural features of these particular arteries.
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C. Fluent Results of the Two-Dimensional Arterial Slices
1. Plots of Scalar0 Mean Age and Nominal Mean Residence Time Comparison
Fluent was used to simulate pulsing blood flow in the two-dimensional arterial
slices while tracking a user-defined scalar (Scalar0), representing the mean age of red
blood cells, over the duration of flow. Again, it is stated that increased peaks of mean age
varying from standard periodicity are indicators of stenotic character along the flow path
as blood attempts to transport from inlet to outlet but is impeded. Succeeding plots with
increased peaks of mean age are shaded gold. With this, the plots utilize area-weighted
averaging of the scalar value instead of mass-weighted averaging for the same reason
explained in the preceding subsection.

1

Area-Weighted Average
of Scalar0

Area-Weighted Average
of Scalar0

The five cases of low 𝐹𝐹𝑅 are shown in FIGURES 4.21–25:
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FIGURE 4.21 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
Patient 004
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FIGURE 4.22 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of

5

Area-Weighted Average
of Scalar0

Area-Weighted Average
of Scalar0

Patient 005

4
3
2
1
0
0

0.5

1
1.5
Flow Time [s]

2

2
1.5

1
0.5
0
0

0.5

(a)

1
1.5
Flow Time [s]

2

(b)

FIGURE 4.23 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
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FIGURE 4.24 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
Patient 019
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FIGURE 4.25 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
Patient 041
As shown, four out of the five low 𝐹𝐹𝑅 cases contain at least one slice (shaded in gold)
with increased peaks of Scalar0 value. Patient 019 saw increased peaks in both arterial
slices, while Patients 005, 017, and 041 contained increased peaks in only one of the two
slices. The appearance (and non-appearance) of high peaks may be attributed to the
arbitrarily chosen planes for slicing. As discussed in EXPERIMENTAL METHODS,
splines were used to create orthogonal slices from a given three-dimensional STL file.
Only two angles out of 360° were created, leading to the possibility of uncaptured
stenotic character within the three-dimensional rendering. Since arteries (and renderings
of them) are not perfectly cylindrical, the potential of observing increased peaks in plots
of Scalar0 mean age is highly dependent on the angular direction chosen for any sliced
plane. The limitation in capturing stenotic character is a possibility in using only two
slices, and this idea serves to explain the unexpected slice singularities of constant peak
value observed and left unshaded in Patients 004, 005, 017, and 041.
The five cases of high 𝐹𝐹𝑅 are shown in FIGURES 4.26–30:
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FIGURE 4.26 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
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FIGURE 4.27 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
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FIGURE 4.28 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
Patient 058
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FIGURE 4.29 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
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FIGURE 4.30 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of
Patient 075
As shown, four out of the five high 𝐹𝐹𝑅 cases resemble periodic functions with a nearly
constant peak value. In fact, aside from Slice 2 of Patient 075, all other slices across the
five cases demonstrate expected behavior. Slice 2 of Patient 075 outlies the total data set
and could be ascribed to natural features of the actual artery that may only be expressed
at this one arbitrary angle.
The peak data of the Scalar0 FIGURES may be tabulated to show the significant
difference of mean age between low and high values of 𝐹𝐹𝑅. With this, peak data of the
Scalar0 FIGURES may be compared to nominal values representing mean residence
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times of blood flow if the geometry were not stenotic. The mean residence times are
determined by dividing the volume of the three-dimensional source rendering by the
volumetric flow rate governing the flow and dictated by the boundary conditions. The
data containing mean age as a function of 𝐹𝐹𝑅 and its comparison to nominal mean
residence time are shown in TABLE 4.2:
TABLE 4.2
A COMPARISON OF MEAN AGE VALUES BETWEEN LOW AND HIGH 𝐹𝐹𝑅
AND TO NOMINAL MEAN RESIDENCE TIMES FOR THE TWO-DIMENSIONAL
ARTERIAL SLICES
Patient
Number

Nominal Mean
Residence Time
[s]

𝑭𝑭𝑹

Peak Scalar0 (Mean Age)

Percent Difference (× 10–1)

Slice 1

Slice 2

Slice 1

Slice 2

004

0.76

1.4 × 10–1

8.8 × 10–1

8.3 × 10–1

53%

50%

005

0.75

9.1 × 10–2

1.5 × 103

5.1 × 10–1

164778%

46%

017

0.72

2.5 × 10–1

4.0 × 100

1.5 × 100

149%

48%

019

0.76

1.5 × 10–1

1.6 × 103

2.3 × 101

111225%

1533%

041

0.70

4.9 × 10–2

4.8 × 104

4.7 × 10–1

9672560%

86%

045

0.83

2.7 × 10–1

5.3 × 10–1

5.3 × 10–1

9%

10%

046

0.98

3.3 × 10–1

2.1 × 100

2.1 × 100

53%

53%

058

0.98

3.5 × 10–1

7.1 × 10–1

7.4 × 10–1

11%

11%

061

0.97

3.0 × 10–1

1.4 × 100

1.3 × 100

37%

36%

075

0.81

2.2 × 10–2

6.6 × 10–1

2.2 × 104

291%

9809017%

“low”

“high”

TABLE 4.2 may be used to emphasize the difference in mean age between low and high
𝐹𝐹𝑅. While high 𝐹𝐹𝑅 cases are observed to range in orders of magnitude from tenths to
ones, low 𝐹𝐹𝑅 cases generally exhibit a mean age increased by no less than one order of
magnitude. Although not always the case (as in Patients 004 and 017), this observation
serves to support the notion of mean age increasing as 𝐹𝐹𝑅 decreases. In addition to this,
TABLE 4.2 serves to emphasize the difference between mean ages and nominal mean
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residence times. The values differ more greatly in cases of low 𝐹𝐹𝑅 than those for cases
of high 𝐹𝐹𝑅, and this is enumerated in the columns of Percent Difference. With this,
Slice 1 values for low 𝐹𝐹𝑅 cases are distinctly higher than respective ones for Slice 2,
which is evidenced by the increased peaks shown previously in the gold-shaded plots in
FIGURES 4.22–25.
The directionality of a slice may have an effect in prompting increased mean age
values, so it is noted here that Slice 1 and Slice 2 geometries were typically cut
horizontally and vertically, respectively, to the trimetric view given by default in
SpaceClaim. An example of this is shown in FIGURE 3.9 in EXPERIMENTAL
METHODS. Resulting treatment in SolidWorks provided the slices shown in FIGURE
4.6, where Slice 1 is now oriented in the XY-plane nearly vertically and Slice 2 is now
oriented nearly horizontally. This procedure was used for all slice creation, provided that
the curvature of the three-dimensional rendering permitted its fulfillment. As shown in
FIGURES 4.1–10, most slices follow this orientation scheme, but there are exceptions
(such as Patient 019 and Patient 046). In viewing these FIGURES and TABLE 4.2,
however, the patients with increased mean age values do not appear to find a correlation
with the orientation of the slice. Directly, while Slice 1 geometries are typically vertical
and represent the cases where increased peaks in mean age are present, Patient 019
displays increased mean age values while both slices are nearly horizontal.
2. Plots of Velocity Contours
The plots displayed in this subsection represent the computed velocity contours of
the red blood cells phase. It is noted that velocity contours of the plasma phase are not
shown since they are indistinguishable with the velocity contours of red blood cells. The
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range of velocity magnitude gradates from blue to red as velocity increases, and the slicespecific spectrum of the velocity is shown in each of the depictions. The velocity
contours for the five cases of low and five cases of high 𝐹𝐹𝑅 are shown, respectively, in
FIGURES 4.31–35 and FIGURES 4.36–40:
𝐹𝐹𝑅: 0.76

(a)

(b)

FIGURE 4.31 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 004
𝐹𝐹𝑅: 0.75

(a)

(b)

FIGURE 4.32 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 005
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𝐹𝐹𝑅: 0.72

(a)

(b)

FIGURE 4.33 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 017
𝐹𝐹𝑅: 0.76

(a)

(b)

FIGURE 4.34 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 019
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𝐹𝐹𝑅: 0.70

(a)

(b)

FIGURE 4.35 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 041
𝐹𝐹𝑅: 0.83

(a)

(b)

FIGURE 4.36 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 045
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𝐹𝐹𝑅: 0.98

(a)

(b)

FIGURE 4.37 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 046
𝐹𝐹𝑅: 0.98

(a)

(b)

FIGURE 4.38 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 058
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𝐹𝐹𝑅: 0.97

(a)

(b)

FIGURE 4.39 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 061
𝐹𝐹𝑅: 0.81

(a)

(b)

FIGURE 4.40 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 075
The most observable difference between low and high 𝐹𝐹𝑅 cases stems from the location
and progression of increased regions of velocity magnitude. For most cases of low 𝐹𝐹𝑅,
regions of red color (high velocity) are confined to discrete spots. Blue/green regions
(lower velocity) typically surround these spots, leading to proper representations of actual
stenoses. Patient 019 displays contours of this characterization, where distinct
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concentrations of increased velocity denote a stenosis and are validated by its plots of
Scalar0 mean age (FIGURE 4.24) and TABLE 4.2 to cause an increased mean age.
Contrastingly, instead of having discrete sites of increased velocity, most cases of high
𝐹𝐹𝑅 exhibit extended lengths of red color throughout a large portion of the slice. This is
attributed to the artery and its slice narrowing naturally along the length of the geometry
without the presence of an actual stenosis. Patient 058 exemplifies this behavior, where a
developed stretch of red color dominates most of both slices, producing no apparent
increase in mean age. This is substantiated by the Scalar0 mean age plots shown in
FIGURE 4.28 and the data of TABLE 4.2. From this, it is generalized that contours of
slices displaying distinct locations of increased velocity as a result of a stenosis typically
influences and dictates an increased mean age value, while those contours with extended,
non-stenotic stretches of maximum velocity do not produce an increase in mean age.
D. Three- and Two-Dimensional Comparison of Mean Age
The mean age data from the three- and two-dimensional simulations may be
compared in an attempt to determine a relationship between the two spatial approaches.
This relationship is sought to determine if reliable results can be obtained that reduces
computational runtime. Directly, CFD processing of three-dimensional flow is typified by
considerably lengthier calculation runtimes when compared to those of two-dimensional
geometries. While three-dimensional calculations often approach a total duration on the
order of several hours, two-dimensional processing usually lasts on the order of about 60
minutes, meaning only about 2% of alike runtime is needed. Ultimately, if twodimensional slicing can produce a similar mean age metric to its three-dimensional
source, the more easily-processed, two-dimensional slices may be preferentially chosen
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to aid in long-term three-dimensional correlative approaches to 𝐹𝐹𝑅. To develop the
relationship of these spatial approaches, the comparison of the two is efficiently
presented by plotting mean age as function of 𝐹𝐹𝑅. The data required for plotting, now
sorting from lowest to highest 𝐹𝐹𝑅 value, are shown in TABLE 4.3:
TABLE 4.3
A COMPARISON OF MEAN AGE VALUES FOR THE THREE-DIMENSIONAL
SOURCE RENDERINGS AND THE TWO-DIMENSIONAL ARTERIAL SLICES
𝑭𝑭𝑹

Patient Number
041
017
005
004
019
075
045
061
046
058

0.70
0.72
0.75
0.76
0.76
0.81
0.83
0.97
0.98
0.98

“low”

“high”

Peak Scalar0 (Mean Age)
Source
Slice 1
Slice 2
Rendering
2.9 × 1013
4.8 × 104
4.7 × 10–1
4.6 × 108
4.0 × 100
1.5 × 100
2.6 × 105
1.5 × 103
5.1 × 10–1
1.1 × 105
8.8 × 10–1
8.3 × 10–1
4
3
1.2 × 10
1.6 × 10
2.3 × 101
8.6 × 103
6.6 × 10–1
2.2 × 104
7.2 × 10–1
5.3 × 10–1
5.3 × 10–1
9.0 × 102
1.4 × 100
1.3 × 100
7.5 × 10–1
2.1 × 100
2.1 × 100
8.6 × 10–1
7.1 × 10–1
7.4 × 10–1

As shown in TABLE 4.3, the mean age values of the slices are contained within a smaller
range in comparison to the source rendering values. Notably, however, TABLE 4.3
serves to enumerate the difference in magnitudes between three- and two-dimensional
processing of related cases as a result of an increasing 𝐹𝐹𝑅 value. Cases of high 𝐹𝐹𝑅 are
typically within one order of magnitude between the source renderings and slices, while,
in contrast, cases of low 𝐹𝐹𝑅 retain mean age values of the source renderings that are
many orders of magnitude higher than those of the corresponding slices. The significant
difference in orders of magnitude between three- and two-dimensional processing of low
𝐹𝐹𝑅 cases may be attributed to the complexity of the source renderings and the
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simplicity of the slices. It is believed that important stenotic proceedings onset and
captured by the complexity of the full three-dimensional source renderings are not
captured by the simplicity of the two-dimensional slices. This is to say that occurrences
such as increased red blood cell collisions around a stenosis or an increase in
recirculatory eddies distal to a stenosis may be less expressed in the two-dimensional
slice systems. As a result, mean ages between the two spatial approaches are quantified
by substantial disparity in order of magnitude.
Setting the value of 𝐹𝐹𝑅 as the ordinate and the value of mean age as the abscissa
of an ordered pair, the data of TABLE 4.3 may be plotted in order to aid in better
visualization. It is noted that while data for Slice 2 are present in TABLE 4.3, they are
shown for completeness and are not used for plotting in subsequent FIGURES. The
previous subsection established that Slice 2 geometries generally provided no increased
peak in mean age, so they are withheld from further discussion. Moreover, it is noted that
source rendering data plotting is performed separately from Slice 1 data plotting. The
increased magnitudes associated with the source renderings make normalization between
its data and Slice 1 data largely ineffectual, so two plots of different scale are created
separately and are shown hereafter
The plot correlating mean age and 𝐹𝐹𝑅 for the three-dimensional source
renderings is shown in FIGURE 4.41:
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FIGURE 4.41 - Quadrant Plot Correlating the Mean Age of Red Blood Cells with 𝐹𝐹𝑅
for the Three-Dimensional Source Rendering
FIGURE 4.41 utilizes a vertical line at the previously identified 𝐹𝐹𝑅 threshold value of
0.80. It is noted that data points to the left of this line dictate cardiological intervention,
while values to the right of this line dictate no intervention. An analogous line of
demarcation is needed for the threshold value of mean age. In order to split the plot into
quadrants, the threshold value of mean age must be determined so as to maximize the
number of data points in the upper left and bottom right portions of the plot. In doing so,
the number of patients mean age is able to diagnose accurately will approach that of the
ability of 𝐹𝐹𝑅. In order to properly determine this threshold value, extensive statistical
analysis is necessary. In this analysis, traditional and visualization techniques such as
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ANOVA and regression are used to test a large set of data to find patterns or trends. Since
the 10 three-dimensional simulation results were previously gathered from a large study
of 80 patients, the threshold value has been statistically determined, and its value is 2.2 ×
104. As such, a horizontal line is plotted at this value, which is shown in FIGURE 4.41, to
further demarcate the data and split the plot into quadrants.
Quadrants I, II, III, and IV of FIGURE 4.41 represent specific regions of
importance with regards to mean age and 𝐹𝐹𝑅 as diagnostics. As mentioned previously,
maximizing the number of data points in Quadrants I and III is desired so as to bring
mean age in close agreement with 𝐹𝐹𝑅. Data points in Quadrant I accurately predict
withholding intervention necessity with low mean age and high 𝐹𝐹𝑅 values, while data
points in Quadrant III accurately predict intervention necessity with high mean age and
low 𝐹𝐹𝑅 values. In contrast, data points in Quadrants II and IV represent predictive
errors in diagnosis and are sought to be minimized. Data points in Quadrant II are false
positives that mistakenly suggest cardiological intervention is necessary, while data
points in Quadrant IV are false negatives that mistakenly suggest intervention may be
withheld. The tabulation of these medical statistics concerning FIGURE 4.41 is shown
subsequently with Slice 1 data in TABLE 4.4.
The plot correlating mean age and 𝐹𝐹𝑅 for the two-dimensional geometry of
Slice 1 is shown in FIGURE 4.42:
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FIGURE 4.42 - Quadrant Plot Correlating the Mean Age of Red Blood Cells with 𝐹𝐹𝑅
for the Two-Dimensional Geometry of Slice 1
Similar to the plot for the three-dimensional source renderings, FIGURE 4.42 utilizes a
vertical line at the previously identified 𝐹𝐹𝑅 threshold value of 0.80. Again, the
analogous line of demarcation for the correct threshold value of mean age must be
determined through statistical analysis. Rigorous tests in statistical analysis ultimately
advance beyond the scope of this investigation due to the limited sample size of twodimensional cases, but an estimation of the threshold value is warranted for
demonstrative purposes. Similar to the quadrant plot for the source renderings, it is
recognized that the threshold value of mean age must seek to maximize the number of
data points in the upper left and bottom right portions of the plot. Therefore, as an
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estimate achieving this goal, the threshold of mean age may be arbitrarily chosen as the
value of 2.5 × 100. Directly, a horizontal line is plotted at this value, which is shown in
FIGURE 4.42, to further demarcate the data and split the plot into quadrants.
Quadrants I, II, III, and IV of FIGURE 4.42 represent the same medically relevant
regions described of FIGURE 4.41 previously. As such, the medical statistics of false
positives and false negatives concerning FIGURES 4.41 and 4.42 are shown in TABLE
4.4:
TABLE 4.4
TABULATION OF THE NUMBER OF OCCURRENCES OF PROPER DIAGNOSIS,
FALSE POSITIVES, AND FALSE NEGATIVES OBSERVED IN THE QUADRANT
PLOTS CORRELATING THE MEAN AGE OF RED BLOOD CELLS AND 𝐹𝐹𝑅
System

Occurrences of
Proper Diagnosis

False Positives

False Negatives

Three-Dimensional
Source Rendering

9

0

1

Slice 1

9

0

1

As shown in TABLE 4.4, only one false negative for each spatial approach is present in
the data when the statistical and arbitrary threshold values of 2.2 × 104 and 2.5 × 100 are
used for the source renderings and Slice 1, respectively. While limited in sample size,
false diagnosis is thusly 10% for each system. In literature, virtual approaches to 𝐹𝐹𝑅
using larger sample sizes have shown false diagnostic values of 10–13% (Papafaklis et
al., 2014; Tu et al., 2014; Tröbs et al., 2016). In order to maintain the presently
competing approach that utilizes multiphase mean age theory, its false diagnostic
percentages should not be greater than those of other virtual 𝐹𝐹𝑅 techniques. For the
present technique, however, the medical statistics shown in TABLE 4.4 aid in
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quantifying similarity between the spatial approaches, and the proper statistical
determination of two-dimensional threshold will rely on this comparison in future
research developments. It is noted that while both medical statistics represent
incongruence with the predictions of 𝐹𝐹𝑅, the overdiagnosis of cardiological intervention
is less problematic than that of underdiagnosing it.
With the data of the quadrant plots shown in full, it is again restated that the line
of demarcation denoting the threshold value of mean age for the two-dimensional data
was chosen arbitrarily. This value serves as a starting point to demonstrate the feasibility
of two-dimensional slicing as a surrogate to equivalently processing a three-dimensional
source rendering. As shown in the previous TABLES and FIGURES, two-dimensional
slicing bolsters appreciable diagnostic similarity to three-dimensional processing when a
subjective mean age threshold has been chosen. These results aid in administering the
preliminary determination of two-dimensional slicing as a meritorious technique
regarding cardiological context, but at least 80–100 data points are needed to confidently
support this claim. Ultimately, with more testing and the employment of proper statistical
analysis efforts, the threshold value of mean age related to the arterial slices may be
confirmed to strengthen the assertions made of two-dimensional blood flow simulations.
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V. CONCLUSIONS
A comparison of stenotic blood flow in two-dimensional arterial slices to flow in
their three-dimensional source renderings was executed using CFD and multiphase mean
age theory. Useful in present research attempting to unite angiography with a noninvasive stenotic evaluator, a relationship between the three- and two-dimensional
approaches was sought to obtain a comparable method of arterial simulation processing
that significantly reduces computational runtime. Computer-aided design software
packages were used to generate two orthogonal arterial slices from DICOM-derived,
three-dimensional STL files of arteries rendered by coronary angiograms. Following
mesh generation by the discretization of the domains of the created geometries, CFD
software was employed to simulate pulsing blood flow in the geometries and to apply
multiphase mean age theory to calculate the mean age of red blood cells using userdefined scalars. Results were presented for five patient cases below and five patient cases
above the commonly accepted 𝐹𝐹𝑅 threshold value of 0.80, below which cardiological
intervention is prompted for stent placement as a mechanism to avert ischemia.
In tracking the area-weighted average of mean age of red blood cells, plots of
mean age throughout the duration of a complete pulse demonstrated peaks with higher
orders of magnitude for cases with 𝐹𝐹𝑅 less than 0.80. The two-dimensional arterial
slices typically exhibited this behavior in only the vertically-oriented geometries of Slice
1. This was ascribed to the limitation of testing only two angles of a 360° arterial
segment, which more than likely eventuated uncaptured stenotic character from the threedimensional renderings within the ineffectual slice. Nevertheless, it was determined that,
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if sliced at a proper angle, two-dimensional slices are able to distinguish between low and
high 𝐹𝐹𝑅.
The increases in mean age for the three-dimensional cases were many orders of
magnitude higher than those of the corresponding two-dimensional cases. This was
attributed to phenomena near a stenosis—such as red blood cell collisions or distal
recirculatory eddies—being less expressed in the simplicity of the two-dimensional
arterial slices when compared to the complex character of the full three-dimensional
source renderings.
Mean age data from the three- and two-dimensional simulations were compared
using quadrant plots to establish the relationship between the two spatial approaches that
administers the determination of two-dimensional slicing as a worthy technique regarding
cardiological context and computational timeliness. Three-dimensional diagnostic ability
was demonstrated by utilizing a statistically analyzed mean age threshold value of 2.2 ×
104, while an arbitrary threshold value (2.5 × 100) demarcating the diagnostic ability for
two-dimensional processing was used since limited sample size impeded full statistical
treatment to obtain it. While not fully statistically grounded, the arbitrary threshold was
used in an analogous manner to that of the 𝐹𝐹𝑅 threshold value of 0.80 to depict the
potentiality of slicing as a proxy to equivalently processing a source rendering. As a
demonstration, this arbitrary value was utilized to indicate the capacity of proper medical
pronouncement, where the medical statistics of false positives and false negatives were
largely outweighed by it.
While three-dimensional calculations often approached a total duration on the
order of several hours while utilizing parallel computing on 20 processors, two-
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dimensional processing required on the order of about 60 minutes on a single processor,
which is less than 2% of the required computing power of the three-dimensional cases.
Preliminary results indicate two-dimensional processing retains compelling calculation
merit and will be well positioned to efficiently detect and assess stenoses non-invasively,
provided that it holds up to rigorous statistical analysis.
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VI. RECOMMENDATIONS
Foremost, an investment into researching other computer-aided design software
should be made in an attempt to simplify and ease the process of generating arterial
slices. As presented in EXPERIMENTAL METHODS, slice generation performed in
SpaceClaim required a combination of tedious rotating, zooming, panning, and clicking
of indiscriminate points along the length of the wall of an artery to create splines that
represented three-dimensional arterial outlines. Researching and testing the capabilities of
other commercially available software may lead to slice generation that is far more
expeditious and aids in ensuring orthogonality of geometry is met. With this, as
mentioned in RESULTS AND DISCUSSION, only two angles out of 360° were created,
which lent credence to the possibility of stenotic character being uncaptured from the
three-dimensional rendering. Ideally, in researching other computer-aided design
software, the ability to revolve a single slice within the boundaries of a three-dimensional
rendering may be discovered so as to foster swift slice generation and permit the creation
of all angles automatically. In doing so, the results of blood flow simulation in all of the
angles may be linked to provide conclusions that more closely mirror the baseline
outcomes drawn from three-dimensional processing.
Other recommendations stem from the amount of cases tested, statistical analysis,
and the meshes used for simulation. Specifically, while 10 cases were analyzed in this
investigation, more DICOM-derived, three-dimensional STL files of arteries rendered by
coronary angiograms could be provided for slicing treatment in an attempt to increase the
repeatability of results, establish better trends, and ultimately further the strength of
gathered assertions. Directly, testing at least 80–100 additional cases of varying 𝐹𝐹𝑅
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value—with a concurrent employment of statistical analysis that establishes the proper
threshold value of mean age—would serve to confidently govern the determination of
two-dimensional slicing as a worthy cardiological technique when compared to alike
processing in three-dimensions. Finally, in testing these extra cases, mesh sensitivity
analysis could be performed as a way to determine whether increasing the element count
of the discretized domain better resolves the flow field and creates improved mean age
data.
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APPENDIX I
SAMPLE SOURCE CODE FOR A UDF FILE
The following source code represents a UDF file that was used to generate pulsing at the
boundaries:
/********************************************************************* */
/*
*/
/* User-Defined Function for Transient Flow in a Channel
*/
/*
*/
/* Fluent 6
*/
/*
*/
/* Author: Frank Kelecy
*/
/* Date: January 2001
*/
/*
*/
/* This function prescribes an oscillating static pressure
*/
/* at the channel exit.
*/
/*
*/
/********************************************************************* */
#include "udf.h"
DEFINE_PROFILE(inlet_velocity,th,i)
{
face_t f;
double t = (CURRENT_TIME*1.111-floor(CURRENT_TIME*1.111))/1.111;
begin_f_loop(f, th)
{
if(t <= 0.42)F_PROFILE(f, th, i) =0.1; else F_PROFILE(f,th,i) =
0.26*sin(1.58*3.141592654*(t+0.92));
}
end_f_loop(f, th)
}
DEFINE_PROFILE(outlet_pressure,th,i)
{
face_t f;
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double t = (CURRENT_TIME*1.111-floor(CURRENT_TIME*1.111))/1.111;
begin_f_loop(f, th)
{
if(t <= 0.42)F_PROFILE(f, th, i)
=0.8*18665.13*sin(1.4*3.141592654*(0.8*t+0.1305)); else F_PROFILE(f,th,i) =(13400*t+22700)*0.8;
}
end_f_loop(f, th)
}
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APPENDIX II
PLOTS OF SCALAR1 MEAN AGE
Fluent was used to simulate pulsing blood flow while tracking a user-defined
scalar (Scalar1), representing the mean age of plasma, over the duration of flow. Scalar1
data for the three-dimensional source renderings were not reported, so the following plots
are for the two-dimensional arterial slices. The five cases of low and five cases of high
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